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Abstract 
      Filament formation by non-cytoskeletal enzymes has been known for decades, yet only relatively 
recently has its wide-spread role in enzyme regulation and biology come to be appreciated. This 
comprehensive review summarizes what is known for each enzyme confirmed to form filamentous 
structures in vitro, and for the many that are known only to form large self-assemblies within cells. For 
some enzymes, studies describing both the in vitro filamentous structures and cellular self-assembly 
formation are also known and described. Special attention is paid to the detailed structures of each type of 
enzyme filament, as well as the roles the structures play in enzyme regulation and in biology. Where it is 
known or hypothesized, the advantages conferred by enzyme filamentation are reviewed. Finally, the 
similarities, differences, and comparison to the SgrAI system are also highlighted.  
 
  
 3 
 
Contents 
INTRODUCTION…………………………………………………………..4 
STRUCTURALLY CHARACTERIZED ENZYME FILAMENTS…….5 
Acetyl CoA Carboxylase (ACC)……………………………………………………………………5 
Phosphofructokinase (PFK)……………………………………………………………………….6 
Glucokinase (Glk1)………………………………………………………………………………...7 
Cytosine Triphosphate Synthetase (CTPS)………………………………………………………..7 
Inositol Monophosphate Dehydrogenase (IMPDH)………………………………………….......9 
Glutamine synthetase (Gln1)……………………………………………………………………..10 
β-Glucosidase……………………………………………………………………………………..12 
Hydrogen-Dependent CO2 Reductase (HDCR)………………………………………………….13 
Nitrilase…………………………………………………………………………………………...13 
CoA-Dependent acetaldehyde and alcohol dehydrogenase (AdhE)…………………………….13 
Glutamate dehydrogenase………………………………………………………………………..14 
Glutaminase………………………………………………………………………………………15 
β-lactamase-like protein (LACTB)……………………………………………………………….16 
2-Cys Peroxiredoxins  (2CPrxs)………………………………………………………………….16 
Ribonucleotide reductase (RNR)…………………………………………………………………16 
Recombinase A (RecA)………………………………………………………………………...…16 
Chromosomal replicator initiator protein (DnaA)………………………………………………17 
SgrAI restriction enzyme (SgrAI)………………………………………………………………..17 
The unfolded protein response nuclease kinase (IRE1)………………………………………...19 
Casein kinase 2 (CK2)……………………………………………………………………………20 
Adenylate kinase (AK)……………………………………………………………………………21 
Receptor-Interacting serine/threonine-protein kinases (RIP1/RIP3 kinases)………………….21 
Death Domain containing proteins that form filaments………………………………………...22 
Target of Rapamycin Complex 1 (TORC1)……………………………………………………...22 
OTHER ENZYMES SHOWN TO FORM FOCI, RODS or  
CYTOOPHIDIA IN VIVO………………………..……………………….22 
Glutamate Synthase (Glt1 in yeast)………………………………………………………………22 
Asparagine Synthetase……………………………………………………………………………23 
Eukaryotic translational initiation factor (eIF2/2B)…………………………………………….23 
GDP-mannose pyrophosphorylase (Psa1)……………………………………………………….23 
Xanthene oxidase…………………………………………………………………………………24 
Purinosome……………………………………………………………………………………….24 
Pyruvate kinase……………………………………………………………………………….…..25 
G-bodies……………………………………………………………………………………….…..24 
Mps1/Polo kinases……………………………………………………………………………..….25 
D-Amino acid oxidase…………………………………………………………………………….25 
Additional self-assembly forming enzymes discovered in large-scale screens………………….25 
DISCUSSION………………………………………………………………26 
Filaments vary in structure…………………………………………………...…………………..26 
Effect of filamentation on enzyme activity……………………………………………………….26 
Filamentation can change enzyme specificity……………………………………………………27 
Regulation of filament formation………………………………………………………………...27 
Direct transformation from one type of filament to another………………………………….…27 
Enzymes that form more than one type of filament……………………………………………...28 
Morpheins…………………………………………………………………………………………28 
Biological roles and possible selective advantages of filament formation by enzymes…………28 
Unique features of SgrAI………………………………………………………………………....30 
CONCLUSIONS……………………………………………………………32 
 4 
 
Introduction     
     For over 50 years it has been known that many enzymes form filamentous structures in vitro as assessed 
by various biophysical assays, including in some cases imaging by electron microscopy (EM)1-16. However, 
it was not generally known how filamentation affected enzyme activity. As protein structure determination 
by x-ray crystallography came to dominate enzyme structure and function studies, enzymes studied tended 
to be those which produced well-ordered crystals, and filament formation by enzymes seemed nearly 
forgotten. However, a handful of laboratories continued to work on this phenomenon and its role in 
regulation of their particular enzyme systems17-22. Then, an explosion of interest occurred with the discovery 
of widespread enzyme self-assembly in cells when viewed by confocal microscopy and with enzymes 
labeled with fluorescent proteins or antibodies23-30. These screens surprisingly found that many enzymes, 
not previously appreciated as filamentous, formed large scale self-assembled structures in cells, including 
foci, rods, and rings, which are sometimes referred to as cytoophidia. These membraneless, reversible 
subcellular structures were often seen in response to cellular stress (nutrient starvation, hypoxia) but in 
many cases they were also seen under normal physiological conditions27, 31.  Controls with alternative tags, 
and the use of orthogonal techniques such as mass spectrometry, confirmed that these observations were 
not merely artifacts of fluorescent labeling such as GFP25, 32-33. In addition, several studies investigated the 
reversibility of the assemblies so as to distinguish from aggregates of misfolded proteins unlikely to 
represent regulatory states of the enzymes25, 28.  
     Enzymes now shown to form nanoscale filaments in vitro and/or self-assemblies in cells come from a 
diverse array of biochemical and biological pathways, and from diverse cell types including bacteria, yeast, 
and metazoans (worms, flies, mice, humans). As such, many have medical significance, such as in 
metabolic diseases, cancer, neurodegenerative disorders, autoimmune disease, and infectious disease. Some 
have biotechnological or industrial applications, such as in the capture of CO2 (CO2 reductase) and 
production of specialized chemicals and bioremediation34. 
     In this review, we attempt to comprehensively collate studies of enzymes found to either form large 
assemblies in cells (with unknown molecular structures) as well as those with filamentous structures known 
in atomic or near-atomic detail. For several enzymes both the molecular structure of the filament is known, 
at least to low resolutions via electron microscopy, and the cellular self-assemblies have been characterized. 
Our particular interest in this phenomenon originated with our studies of SgrAI, a type II restriction 
endonuclease with unusual allosteric behavior, where binding to one type of DNA sequence results in 
activation of the enzyme to cleave 14 additional DNA sequences35. Our investigation into the mechanism 
responsible for this behavior led to the discovery of filament formation by SgrAI when bound to the 
activating DNA (which is also a substrate for cleavage of SgrAI known as primary site sequences)17, 36-37. 
The filamentous form recruits additional copies of SgrAI bound to the second type of DNA sequence 
(secondary sites)17, 38. The filamentous state preferentially stabilizes the activated conformation of the 
enzyme, hence SgrAI in the filament is activated for DNA cleavage39. In reviewing the literature for 
precedence of this type of behavior, we discovered that such phenomenon were also under investigation in 
the regulation of IRE1 (the unfolded protein response kinase/ribonuclease)18, CTP synthase19, 24, 27, 40-41, and 
acetyl CoA carboxylase (ACC)20. Concurrently, the publication of proteome-wide screens for self-
assemblies in cells, as well as older literature showing filamentation by a number of metabolic enzymes, 
became relevant to our studies and are also covered in this review. 
     Several other reviews have been published recently regarding enzyme filamentation26-27, 42-49. We focus 
here in this review on structure-function studies of filament forming enzymes, while also attempting to 
provide an up-to-date, comprehensive listing of enzymes known to form cytoophidia or intracellular self-
assemblies. We attempt to find similarities and differences in the structures and mechanisms, and are 
particularly interested in why filament formation is necessary in addition to more “traditional” enzyme 
regulatory mechanisms. Our own studies with SgrAI indicate that filament formation provides for a much 
faster activation of the enzyme50. We also find that due to a particularity of the enzyme kinetic pathway, 
namely a relatively slow, rate limiting second order association rate constant for filament assembly, that 
filament formation can provide a means to sequester enzyme activity on only particular substrates of 
interest, those with high local concentrations50-52. This could be a general phenomenon for enzymes that 
have more than one class of substrate and require regulation of when and where that secondary substrate 
activity will occur. However, it remains to be seen for the vast majority of enzymes known to filament, 
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what advantage filamentation has towards enzyme function and/or regulation. What is known in general, 
considering all enzymes reviewed herein, is that filamentation can occur through linear polymer assembly 
or more commonly helical assembly (left or right-handed). The filament form may either be the more active 
form, or the less active form, or may have altered activity (substrate preference or even a completely 
different type of activity). The purpose of filamentation may be to perform a structural function, such as 
determining cell shape, or may form a scaffold for the binding of other proteins. As such, it can sometimes 
perform functions in signaling. Filament formation can be responsive to cellular conditions, thereby 
regulating enzyme activity and any other activity such as signaling or chaperone function. All in all, enzyme 
filamentation has been found to perform many different functions in cells, and we are likely to continue to 
discover new roles and functions for this interesting phenomenon. 
 
Structurally Characterized Enzyme Filaments 
Acetyl CoA Carboxylase (ACC) 
     Acetyl CoA carboxylase (ACC) has a central role in primary metabolism, and its upregulation is linked 
to obesity related diseases53-55 and tumor growth56-58. This enzyme catalyzes the carboxylation of acetyl-
CoA to malonyl-CoA, the first and a rate-limiting step of fatty acid biosynthesis. The ACC enzyme uses 
biotin as a carboxyl carrier, requires adenosine triphosphate (ATP), and uses bicarbonate as a carbon 
donor59-61 (Fig. A1A). Mammals contain two isoforms, ACC1 and ACC259. While both isoforms produce 
malonyl-CoA, ACC1 is found in lipogenic tissues, is predominantly cytosolic, and generates malonyl-CoA 
that is used for fatty acid synthesis. ACC2 is mitochondrial and is found mostly in oxidative tissues, such 
as heart and skeletal muscle where it regulates fatty acid beta-oxidation because its product, malonyl-CoA, 
is a negative regulator. Hence, ACC2 has been identified as a potential target for treating metabolic 
syndromes because knockout of ACC2 reduces fat content and increases the resistance to high fat/high 
carbohydrate-induced obesity and diabetes62-64. 
     Mammalian ACCs are typically homodimeric, but can also assemble into polymers with increased 
activity (~60 fold)2-3. ACCs are regulated by a complex interplay of phosphorylation, binding of allosteric 
regulators and protein-protein interactions, which is further linked to filament formation1, 53, 65-68 (Fig. 1b). 
These filaments were discovered 50 years ago1-2, 69 but only more recently were they shown to be relevant 
to in vivo activity and to be characterized structurally20. Polymerization of ACC1 increases enzymatic 
activity and is induced in vitro by supraphysiological concentrations of citrate (> 5 mM)2-3.  Citrate is 
produced in the mitochondria and is used as a substrate by ATP citrate lyase, which converts citrate to 
acetyl-CoA, the substrate of ACC.  
     Filament formation is also modulated by other proteins. For the mitochondrial isoform of ACC (ACC2), 
midline-1-G12-like-interacting protein (MIG12) binding alone is sufficient to drive polymerization20. The 
presence of MIG12 further reduces the concentration of citrate needed for polymerization fivefold for the 
cytoplasmic isoform ACC1 (to <1 mM), and also increases the activity by ~60-fold20. However, Spot14, a 
paralog of MIG12, forms assemblies with MIG12 which attenuates activation and filament formation by 
both ACC1 and ACC270. 
     A recent structural investigation showed the formation of three different types of filaments of human 
ACC171 (see Fig. 1c). The authors used cryo-electron microscopy and single particle reconstruction to 
reveal filaments at 4-6 Å resolution, allowing the fitting of previously determined crystal structures into the 
cryo-EM envelopes. The basis of activation or inactivation in the filaments resulted from the locking in of 
either an active or inactive conformation, compared to nonfilamentous ACC1 that was shown to populate 
both active and inactive conformations. One type of filament is activated, due to the dimerization of its two 
biotin carboxylase (BC) domains (which is required for activity), while the other two show these domains 
are not in close proximity, and are inactive.  
     The active filament (ACC-citrate) is formed in the presence of citrate (at 10 mM), and only with a form 
of ACC1 that is free of phosphorylation. The filament is a run-on oligomer, as it is composed of a linear 
polymer of ACC1 dimers which appear to add singly at either end. The filament is a left-handed helix, with 
three ACC1 dimers per turn and a rise (distance between adjacent ACC1 dimers in the filament) of 154 Å. 
In the active filament, not only are the BC domains dimerized, but also the BCCP (biotin carrier protein 
domain) is in a position where it may rotate to carry the biotin from the BC to the CT (carboxyl transferase) 
domain (Fig. 1d). These filaments can be quite long at 0.5-1.0 microns in length. 
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     A second filamentous form of ACC1 is induced by the addition of a tenfold molar excess of the feedback 
inhibitor palmitoyl-CoA to the filament form of ACC1 induced by citrate. This form, ACC-citratepalm is 
presumably inactive, as the BC domains are no longer dimerized. The helical backbone is thinner from 
which the BC domains now protrude, although the filament still shows 3 copies of the ACC1 dimer per 
helical turn (left-handed)(see Fig. 1b). 
     A third type of filament results from binding of the BRCT domains of BRCA1 to a phosphorylated form 
of ACC1 (ACC-BRCT). Phosphorylation at Ser78, Ser80, Ser1201, and Ser1216 are known to inactivate 
human ACC1, with Ser80 and Ser1201 phosphorylation having the greatest effect65. Mutations in the BRCT 
domains eliminating BRCA1 binding to ACC result in elevated lipogenesis, which is a prerequisite for 
cancer cell growth72-73. The C-terminal tandem BRCT domains of BRCA1 bind ACC1 by recognizing 
phosphorylated Ser1263, a residue that is phosphorylated in a cell cycle dependent manner, and this binding 
inhibits dephosphorylation of Ser80 of ACC172-74. This filament is distinct in that it has a two-stranded 
appearance, with a rise of 190 Å between adjacent ACC1 dimers. However, it is also a left-handed filament 
with 3 ACC1 dimers per turn. The BRCT domains laterally “decorate” the filament, and interlink adjacent 
ACC1 dimers. Like the ACC-citratepalm filament, the BC domains are monomeric and the BCCP domains 
appear to be sterically unable to reach any of the active sites, hence the ACC1 in this form is predicted to 
be enzymatically inactive. 
     Large assemblies (i.e. cytoophidia) of ACC are seen in screens, including that of Shen et al (2016)26 
under conditions of nutrient starvation (in stationary phase)(Fig. 1e). These are much larger than the 
filaments viewed by EM (Fig. 1c), but may be made of bundles of likely inactivated enzymes. 
 
Phosphofructokinase (PFK) 
      Phosphofructokinase (PFK) is an important metabolic enzyme that acts as a gatekeeper since it 
unidirectionally catalyzes the committed step of glycolysis, namely the conversion of fructose 6-phosphate 
(F6P) to fructose 1,6-phosphate (F16P)(Fig. 2a). Glycolysis is the core of central carbon metabolism; its 
intermediates provide precursors important for generating ATP through glucose oxidation, serine for one-
carbon metabolism, sugars for protein glycosylation, and building blocks for nucleotide synthesis through 
the pentose phosphate shunt. Due its importance in cellular metabolism, it is highly regulated with allosteric 
regulation by over 10 metabolites to allow cells to fine tune their energy needs. PFK from yeast, C. elegans, 
and human liver have been shown to form filaments, fibers, and/or punctate foci26, 75-76. The in vitro self-
association of purified rabbit liver PFK has been known since at least 1971, using size exclusion 
chromatography4. Follow-up studies using sedimentation, analytical ultracentrifugation, and fluorescence 
anisotropy also showed PFKL self-assemblies5-6. Finally, negative stain EM performed in 1980 showed 
these to be composed of filaments77, which was further investigated recently (Fig. 2b)76. Filament formation 
occurs with starvation  in yeast26, stress from increased activity and/or hypoxia in neurons of C. elegans75, 
and high concentrations of citrate or its substrate F6P in human PFKL (Fig. 2c)76, suggesting a role in 
enzyme regulation. However, the effect of filamentation on enzyme function are not currently known. 
Dysregulation of PFK activity has implications for cancer 78-81, neuronal disfunction 75, type II diabetes82-83 
and autoimmune disease84. A low-resolution structure of the filament formed by human PFKL has been 
reported using single particle reconstruction and negative stain TEM (Fig. 2d)76. No high-resolution 
structures or structures of PFK filaments are known, though crystal structures of non-filamentous PFK have 
been reported78, 85-88. Fitting of the non-filamentous structure into the low-resolution EM envelope of the 
PFKL filament shows a right-handed helix with stacked PFKL tetramers related by a rotation of 221° and 
translation of 83 Å between subunits (Fig. 2e)76. The average size of filaments observed by EM is 6 
tetramers, although filaments of 11 or more were also observed76. Filaments were observed to be kinked at 
random locations (Fig. 2b), and structural analysis revealed that for every addition of PFKL tetramer, two 
possible interfaces are possible. One interface leads to an unkinked junction, the other to a kinked junction 
of ~130° (Fig. 2f-h)76. In vivo, TIRF was used to show punctate foci of PFKL in cells, and indicated that 
filaments must be smaller than 15 tetramers in length, consistent with the EM results (Fig. 2b)76.  
     No detailed kinetic analyses of the role of filament formation in PFK function have been reported. 
Therefore, the following questions remain unanswered: how does filament formation affect PFKL enzyme 
activity? It’s stimulation by its substrate suggests activation, however it is also stimulated by the inhibitory 
effector citrate. Also, how do its 10 allosteric effectors affect filament formation and PFKL activity? 
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Allosteric effectors include: ATP (a required reactant but also an allosteric inhibitor at higher 
concentrations), ADP (a product of the reaction, but also an allosteric activator), fructose 2,6-phosphate 
(activator) and citrate (inhibitor), among many others. Further, what advantages does filament formation 
confer to PFKL function?  
 
Glucokinase (Glk1) 
     Glucokinase (Glk1) is found in fungi, and one of three kinases in S. cerevisiae that initiate glycolysis by 
phosphorylating glucose in an ATP-dependent reaction (Fig. 3a), and also possesses an actin fold. The 
enzyme is induced in the absence of glucose, and expressed in high glucose89. A fusion protein of Glk1 and 
GFP is found to be diffused throughout the cytoplasm in the absence of glucose (Fig. 3b, left), but formed 
fiber-like self-assemblies in the presence of glucose (Fig. 3b, right)90. These bundles rapidly disassemble 
when glucose was removed from the growth media90. Purified Glk1 at 7.5 µM is nonfilamentous in the 
absence of ligands (Fig. 3c, left), but was found to form helical filaments in vitro in the presence of its 
substrates (ATP and glucose, mannose, glucosamine) or products (ADP and sugar-6-phosphate)(Fig. 3c, 
right). No filaments were formed in response to pH, fructose, or galactose (fructose and galactose result in 
fiber formation in vivo)90. Some polymerization is found with N-acetylglucosamine-6-phospahte and N-
acetylglucosamine, inhibitiros of Glk190. 
     Polymerization of Glk1 in vitro was found to occur with a critical concentration of 2 µM, below which 
the enzyme remains unpolymerized and active, but above this concentration the enzyme forms polymers 
with little to no activity90. Therefore, below 2 µM, product formation increases with enzyme concentration, 
however above 2 µM, the rate of product formation is independent of enzyme concentration. Above 2 µM, 
the concentration of non-polymerized enzyme remains constant while the concentration of enzyme in the 
filaments increases with increasing overall enzyme concentration. This in effect, results in an upper limit 
to the enzyme activity, which may play a role in protecting the cell against excess toxic enzyme activity. 
Assembly of filaments was also found to be rapid, reaching the steady-state equilibrium in a matter of 
seconds90. 
     The filament structure was determined using cryo EM (Fig. 3d) and found to be an anti-parallel double 
stranded, right-handed helix90. The enzyme is confirmed to be in the closed state, and evidence of ATP 
binding in the active site is found90. Each enzyme copy makes extensive contacts to enzyme copies before 
and after in the same filament, as well as the copy opposite it in the other strand90. The contacts between 
enzymes are distinct from those found in actin, and evolutionary considerations indicate that polymerization 
by Glk1 evolved independently from that of actin90. Being an anti-parallel, double helical filament, it has 
no polarity and one end is equivalent chemically to the other. No larger bundles of the dimensions formed 
in vivo were found in vitro, indicating that those larger self-assemblies in cells are the result of filaments 
assembling due to crowding, filament binding proteins, or even possibly due to the GPF tag.  
     Polymerization was found to be important for cell fitness, as mutants that eliminate filamentation 
without affecting the enzymatic activity of non-polymerized Glk1 show reduced survival compared to wild 
type90. Protecting the cell from toxic excess sugar kinase activity is important, and Glk1, unlike the two 
other similar kinases Hxk1 and Hxk2, which do not polymerize, is not inhibited by trehalose-6-phosphate 
(a metabolic intermediate that transiently accumulates as a result of elevated glucose 6-phosphate)90. 
Stoddard, et al (2019) argue that Glk1 polymerization evolved as a strategy to allow cells to adapt to 
environmental transitions occurring faster than the cell can change its protein levels90. 
 
Cytosine Triphosphate  Synthetase (CTPS) 
     CTP synthase (CTPS) is a universally conserved enzyme that forms filaments in vitro and rod-shaped 
self-assemblies in cells, both the bacterial and eukaryotic cells. This enzyme is a focal point for regulating 
pyrimidine levels through its formation of CTP from UTP (Fig. 4a), and is a target for cancer, 
immunosuppressive, and antiparasitic drugs91-95. Cytoophidia, or large rod-like self-assemblies, were seen 
with GFP labeled CTPS in yeast under conditions of nutrient starvation24 (Fig. 4b). Such structures were 
also discovered in the bacteria Caulobacter crescentus19 and E. coli96. Filament formation by the bacterial 
enzyme inhibits its enzymatic activity, is required for nucleotide homeostasis, and its disruption 
significantly affects cell growth and metabolism96-97. In bacteria, the product (CTP) drives filamentation, 
which may also have a role in cell shape19. The filaments are also sensitive to the balance of substrate and 
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product and can rapidly dissociate into active tetramers in response to changes in substrate concentration98-
99. These dynamics may act to buffer the catalytic activity of CTPS97. A negative stain EM image of 
filaments formed by a bacterial CTPS is shown in Figure 4c. 
     Human CTPS, in contrast to the bacterial, forms filaments with increased enzymatic activity, and an 
image of negative stain EM is shown in Figure 4d98. The bacterial and human CTPS filaments also differ 
considerably in overall filament architecture and conformation of the enzyme98. Filament formation by 
human CPS is favored in the presence of substrates UTP and ATP, but not the products, CTP and ADP98. 
Filaments assembled with substrate are disassembled upon addition of glutamine presumably due to 
accumulation of CTP, but using nonhydrolyzable AMPPNP stabilizes filaments against disassembly98. In 
eukaryotes, cytoophidia and filament formation is part of a stress response and varies with developmental 
state in some organisms32, 40, 97, 99-101. CTPS in Drosophila germ cells form cytoophidia at developmental 
stages with a high demand for CTP100. CTPS activity is regulated by phosphorylation102-104, but it is not 
known if phosphorylation has an effect on polymerization. CTPS cytoophidia colocalize with other 
metabolic and signaling enzymes too, raising the possibility that other enzymes may regulate CTPS filament 
formation and/or be incorporated into the filaments31. 
     The homotetrameric structure of CTPS is conserved between eukaryotes and bacteria105-108. Each 
monomer is glutamine amidotransferase doman (GAT) fused to kinase-like ammonia ligase domain (AL) 
via an alpha helix linker. Ammonia from GAT is transferred to AL, and ligated to UTP forming CTP in 
ATP hydrolysis dependent reaction105. The 4.6 Å Cryo-EM reconstruction of the bacterial (E. coli) CTPS 
(ecCTPS) filament (Fig. 4e, right) with bound inhibitor CTP shows that it is formed from stacked tetramers 
that interact through the GAT & linker domains98. These authors also solved a crystal structure of ecCTPS 
in a non-filamentous form with bound CTP, and found the same conformation of the enzyme and CTP 
binding. This result is significant in that it supports an idea that the filament locks in an inhibitory 
conformation of the enzyme, and that CTP binding allosterically controls ecCTPS and filament formation 
by inducing a filament competent conformation in the enzyme. Notably, a mutation associated with drug 
resistance in CTPS, E155K, eliminates the ability to form filaments96, 109. Significantly, the mutant CTPS 
lacks the large reduction in activity found with wild type upon filament formation, and binds CTP less 
tightly. These results indicate a role for filament formation in providing an added layer of regulation in the 
form of rapid and efficient inhibition.  
     To further investigate the mechanism of inhibition of ecCTPS via filament formation, disulfides were 
engineered to create a filament that could be formed without the addition of product nucleotides (i.e. CTP, 
ADP)(Fig. 4c), and it was found to have a five-fold reduction in activity, consistent with the filament 
directly inhibiting activity. Products soaked into these filaments bind, as observed by cryo-EM, hence the 
filament structure is not occluding CTP or ADP binding sites. However, when repeated with substrates 
UTP and ATP, no binding was seen. It was concluded that the filament allosterically regulates ecCTPS 
activity by stabilizing an intrinsically lower-activity state upon incorporation into filaments, independent 
of CTP binding98.  
     The structure of the filament of human CTPS has been determined to 6.1 Å by cryo-EM (Fig. 4e). These 
form in the presence of substrates UTP and ATP (and the allosteric effector GTP), but not CTP and ADP 
products, exactly the opposite of ecCTPS98. The structure also shows stacked tetramers, however with 
different assembly contacts, tetramer interfaces, and protomer conformations than the bacterial CTPS 
filament98. Filament assembly is mediated primarily via an insertion in the GAT domain that appeared early 
in eukaryotic evolution. But like ecCTPS, filament formation is driven by binding to allosteric effectors, 
however with the opposite result on activity, enzyme conformation, and with different filament 
architectures (Fig. 4e). A mutation in the GAT domain insert that mediates filament interactions between 
tetramers, H355A, forms the native tetramer but not the filament, and shows a 6-fold reduction in activity. 
This is consistent with the filament having the function of holding the enzyme in an active conformation. 
The active conformation appears to be the result of a 10° rotation between the GAT and AL domains, 
relative to all previously reported structures, which results in a tunnel that could be used for ammonia 
transfer between the two active sites. The rotation connected to filament assembly since it is also necessary 
for positioning the GAT domains for interactions between CTPS tetramer in the filament. 
     Both types of filament appear to have ~3-4 CTPS tetramers per turn Fig. 4e). The ecCTPS associates 
via interdigitation of stacked Xs (each X is a CTPS tetramer), while hCTPS associates by Xs interacting at 
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their “tips”. The “X” is a little different in the two as well, as it is somewhat elongated in one direction (that 
which coincides with the filament axis) and compressed in the other (by 5-6 Å each). Both polymerize via 
their GAT domains. The short helical insertion in human CTPS provides the primary assembly interface 
and also prevents the formation of ecCTPS-like contacts98. 
     What remains unclear is the relative advantage of stabilizing hCTPS in an active conformation in the 
filaments. It could be to keep the bulk of the enzyme under conditions of cellular stress in a state primed 
for maximal activity immediately on return to normal growth conditions. 
 
Inositol Monophosphate Dehydrogenase (IMPDH) 
     The precise regulation of nucleotide biosynthesis is crucial for normal cell metabolism110. Like CTPS, 
which forms the rate limiting metabolite in the de novo synthesis of CTP, IMPDH catalyzes the rate limiting 
step for the synthesis of GTP (Fig. 5a). The substrate of IMPDH, inositol monophosphate (IMP), is 
generated by a large complex of related enzymes called the purinosome111-112. However, IMPDH is not part 
of the purinisome, perhaps why it forms super-structures of its own. IMPDH is an important drug target 
(antiviral, antiparasitic, antileukemic, antibacterial, and immunosuppressive113-117) because inhibition 
causes not only a reduction of the guanine nucleotides pools, but also more importantly an imbalance 
between adenine and guanine nucleotides, leading to wide-ranging repercussions117. Humans code for two 
differentially expressed IMPDH genes (IMPDH1 and IMPDH2)118, and both have been shown to assemble 
into the large rod and ring shaped assemblies visible in cells as cytoophidia (Fig. 5b)119-120. In Drosophila, 
IMPDH has also been shown to bind to DNA and repress transcription of histone and E2F genes121. E2F is 
critical for the G1/S transition and DNA replication, hence this activity of IMPDH would result in slowing 
the cell cycle. In contrast, the enzymatic activity of IMPDH is under higher demand in proliferating cells. 
     IMPDH has been shown to form cytoophidia in vivo in mammalian cells as well as in Drosophila31, 40, 
122. CTPS also forms these types of structures, and cytoophidia of CTPS and IMPDH are often are observed 
at the same time, often colocalizing but other times forming separate structures40, 123-124. Keppekke et al. 
(2015)125 showed that CTPS and IMPDH cytoophidia were independent but related structures124. The sizes 
and locations can also be very different for the two types of assemblies, even in the same cell125. There is 
also currently no evidence that these two enzymes form mixed filaments. 
     IMPDH cytoophidia are found to occur spontaneously in a number of cell types, but can also be 
induced46, 126. IMPDH cytoophidia assembly is promoted by its substrate IMP124. They form spontaneously 
in mouse pancreatic islet cells in response to nutrient uptake126. Formation of the IMPDH cytoophidia in 
mouse embryonic as well as induced pluripotent stem cells is correlated with rapid cell proliferation40, 124. 
When cells launch division, they must increase nucleotide production before or during S phase to meet the 
needs of protein expression and DNA replication. IMPDH cytoophidia can also be induced in cells by the 
addition of inhibitors that impede GTP biosynthesis, such as MPA122,  ribavirin46, or by depleting essential 
purine precursors99. Disassembly of cytoophidia can be induced by the addition of the downstream product 
guanosine or GTP40, 120, 122. Cellular IMPDH cytoophidia can also be reduced by disrupting the cell cycle 
through the PI3K-AKT-mTOR pathway using a PI3K inhibitor126. These results again support the 
hypothesis that upregulation of purine nucleotide synthesis promotes IMPDH cytoophidia assembly. 
IMPDH form abundant cytoophidia in mouse pancreatic islet cells, which correlate with insulin secretion 
(occurring in the fed, but not starved state)126, and they are also developmentally regulated97. In summary, 
cytoophidia by IMPDH1 and IMPDH2 appear to be required for producing sufficient amounts of guanine 
nucleotides to maintain normal cell proliferation when the intracellular IMPDH level is not adequate124. 
     Cellular cytoophidia are large structures, which are likely composed of bundles of filaments. Human 
IMPDH2 filaments have been structurally characterized by electron microscopy127-128 (Fig. 5c-d). EM 
revealed two types of filament structures, one appearing under conditions giving rise to activated IMPDH 
(the octamers have an “open” configuration and they form with NAD+), and the other with inactive (the 
octamers have a “closed” conformation and form with GTP)128 (Fig. 5d). Both types of filaments are 
induced by ATP, and are composed of stacked octamers with 30° (open conformation) or 35.5° (closed 
conformation) between them128(Fig. 5d-e). A domain of IMPDH, the CB domain, binds MgATP and is 
responsible for allosteric activation of Pseudomonas aeruginosa IMPDH127, and human IMPDH without 
CB domain do not form cytoophidia124. 
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     Although the cellular superstructure known as ctyoophidia (or “rods and rings”) appear to form under 
conditions of active IMPDH, the EM study finds that filaments may be composed of either active or 
alternatively of inactive enzymes. To investigate the relationship between enzyme activity and 
filamentation, a study was performed with mutations that either impair filamentation or result in constitutive 
formation of filaments128. It was found that wild type IMPDH and mutants that either promote or inhibit 
polymerization have comparable catalytic activity, substrate affinity, and GTP sensitivity. This is also true 
when expressed in living cells (HEK 293)128. Unlike other metabolic filaments (i.e. CTPS), which 
selectively stabilize active or inactive conformations, recombinant IMPDH filaments accommodate 
multiple states. These conformational states are finely tuned by substrate availability and purine balance128. 
Anthony, et al. (2017)128 suggest that polymerization may allow cooperative transitions between states, 
where effectors can rapidly modulate the activity of the entire IMPDH population perhaps using a switch-
like transition128. They also postulate that the filaments could also be a platform for other regulatory 
proteins, the conformational state providing a physical signal for the level of guanine biosynthetic 
activity128. Finally, given the transcriptional activity observed in Drosophila IMPDH, the filaments could 
serve to sequester IMPDH it from its nuclear functions121, 128. 
 
Glutamine synthetase (Gln1) 
    Glutamine Synthetase is an essential enzyme that synthesizes glutamine from glutamate and ammonium 
in an ATP dependent manner (Fig. 6a). It is found in all forms of life, and for plants, it is a critical factor 
in nitrogen fixation. In bacteria, it functions as a regulator of glutamine level. In higher organisms, it has 
critical functions in maintaining proper hormonal levels in neurons, particularly astrocytes. The enzyme 
catalyzes the activation of glutamate to phosphoglutamate with energy from ATP. Upon activation with 
ATP, the structure of the active site around the phosphoglutamate undergoes a rearrangement allowing 
binding of ammonium129. After enzymatic ammonium deprotonation, the ammonia attacks the intermediate, 
yielding products which may leave by opposite sides of the enzyme ring structure129.  
     The various isoforms of glutamine synthase are regulated in many ways129. Many free amino acids 
inhibit the enzyme by binding the substrate site. Glycine, alanine, and serine have backbones that bind in 
the same orientation as the substrate glutamate. The activating nucleotide site can be inhibited by ADP, 
AMP, and GDP. In prokaryotes, glutamine synthase is regulated by adenylylating a critical active site 
tyrosine. However, all 12 protomers of the dodecamer need to be modified in order to stop the enzyme’s 
activity. This can be an energy intensive process because the adenylylation requires ATP. In E. coli it is 
known that regulation is also carried out by specific proteins at the genetic level. Presumably genetic 
regulation is found in all branches of life. In eukaryotic non-brain tissue, GS is inhibited by glutamine 
metabolism end products.  However, brain tissue does not seem inhibited this way. Filamentation may be 
another form of controlling activity, likely by inhibition, at the structural level and we are just beginning to 
investigate this. 
     Gln1 is an isoform of glutamine synthetase that was found in metabolic screens of yeast cells under 
starvation as well as heat stress conditions where fluorescent versions of the enzyme were seen 
microscopically in foci, rods, rings, fibrils, and related large self-assemblies (often referred to as 
cytoophidia)130. Petrovska et al. (2014)101 have directly tested the effect of various fluorescent tags on Gln1 
in yeast and found cytoophidia persist under starvation conditions. Although there is a propensity for GFP 
to induce aggregation, cytoophidia were found when Gln1 was fused to mCherry, and tetracysteine-binding 
fluorophores (Fig. 6b). The conclusion from Petrovska et al. (2014)101 is that Gln1 in yeast is a cytoophidia-
forming enzyme that conserves energy involved in protein synthesis by storing this important metabolic 
catalyst in until starvation conditions are reversed. Interestingly, the cytoophidia formation started nearly 
one hour (50 minutes) after advanced starvation conditions. Upon reintroduction of glucose, cytoophidia 
dissolved within 18 minutes and cells were available to reenter the cell cycle.  
     Glutamine synthetase cytoophidia were investigated separately by Narayanaswamy et al. (2009)25 and 
Petrovska et al. (2014)101. The fluorescently labeled structures in yeast resemble punctate foci or short rods. 
Narayanaswamy et al. (2009)25 showed that the foci formation by Gln1 was stimulated by absence of 
adenine in growth media, and could be reversed upon the addition of glucose. Gln1 punctate body formation 
was not inhibited by the addition of the protein translation inhibitor cycloheximide, while those of Gln1 
were not. These foci did not colocalize with P-body marker proteins and only in a limited way with actin 
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bodies. Pelleted purified Gln1 punctate foci could not be dissolved into soluble protein by the addition of 
rich media. 
     He, et al. (2009)131 solved the crystal structure of Gln1 from yeast and found pentameric rings that 
stacked in the asymmetric unit (a total of 4 rings)(Fig. 6d).  This suggests that stacking of the rings is the 
basis for forming the larger self-assemblies visible in cells and by EM. There is an asymmetry to the 
stacking. The decamer forms from two pentameric rings that sit next to each other (i.e. front-to-back) with 
a 30° rotation between the rings. The interaction between pentamers in the functional decamer seems to be 
mediated by a large amount of looping structures and driven primarily by hydrophobic interactions (1900 
Å2) and 10 hydrogen bonds. The back-to-back interaction (1700 Å2) that allows decamers to self-associate 
into the stack of 4 pentameric rings seen in the asymmetric unit has a 10° rotation in the same direction as 
that between rings in decamers. The residues in the area defining the decamer-decamer interaction seem to 
be highly charged which seems to mediate binding presumably in pH or charge dependent manner.  
     Petrovska et al. (2014)101 also formed an inducible Gln1 mutant yeast strain that could be controlled. By 
stopping further translation of Gln1 under starvation conditions, they found that the yeast was able to 
respond to new supplies of glucose. This indicates that the formed cytoophidia from Gln1 could form the 
basis of new active enzymes once the cytoophidia dissolved. Petrovska et al. (2014)101 used correlative light 
electron microscopy to show the foci and punctae seen in fluorescent images are in fact clusters of aligned 
fiber segments approximately 1 micron long (Fig. 6e). Further, attempts to purify the fibers from mutants 
or starved cells, resulted in dispersions of decamers. However, fibers could be reconstituted in vitro by 
addition of 200 mg/mL Ficoll 70 as a crowding agent. 
     Enzymatic activity falls 60% for mutants in low pH media or starved cells relative to well-fed wild type 
enzyme. This activity can be recovered for the wild type or in some mutants, by reversing cellular or in 
vitro conditions. The loss in activity seems to correlate with the extent of cytoophidia/fiber formation101. 
Gln1 has a theoretical pI of about 6. Changes in cytosolic pH would then reduce its net charge indicating a 
possible electrostatically governed interaction. Alternatively, protons could act as allosteric effectors 
changing the structure and/or interfaces. Charge flipping by the mutation E186K was seen to be important 
in keeping pentameric rings dispersed101. But then charge reversal for R23E stabilizes cytoophidia and 
filaments made of the same rings101. Thus, there may be an overall electrostatic effect, for example, 
increasing the negative charge stabilizes filaments and filaments, while increasing the positive charge 
stabilizes pentameric rings.  
     Petrovska et al. (2014)101 tested the hypothesis that these residues are responsible for cytoophidia 
formation in a pH dependent manner. Interestingly, as the cells become acidic due to starvation 
conditions132-134, the cytoophidia formation seems to be enhanced. In glucose containing media with well-
fed yeast, the pH was dropped by addition of the chemical reagent 2,4 dinitrophenol and cytoophidia were 
observed. Mutants tested were in several classes. E186K, P83R, T49E were capable of preventing 
cytoophidia formation. Y81A had enhanced starvation-induced cytoophidia and R23E formed cytoophidia 
in both starvation and well-fed conditions. In fact, they found that the Y181A mutant had decreased rate of 
return to normal cell cycle after starvation induced cytoophidia. They concluded that the return to normalcy 
is limited by the rate of fiber dissolution.  These cytoophidia-stabilizing mutants grew poorly in regular 
media but could grow normally when the media was supplemented with glutamine. Interestingly, the mixed 
effect T49E, R23E double mutant shows a strong resistance to cytoophidia formation indicating the relative 
strength of these two mutants. Imaging of the self-assemblies of purified R23E Gln1 from yeast (a mutant 
form that constituitively formed cytoophidia in cells101) using negative stain EM shows filaments that 
appeared to be composed of stacked rings, as was predicted by the x-ray crystal structure (Fig. 6c). 
     There are a number of advantages thought to be important for Gln1 self-association. There is likely a 
resistance to bulk autophagy for these enzymes. Also, having functional, oligomerized enzymes ready to 
react as cellular conditions revert from starvation is an advantage over having to synthesize new enzymes 
from nucleic acid sequences. This further conserves cellular energy as has been proposed for mammalian 
cells containing ADF/cofilin filaments135-136. In fact, it may be that there is a small amount of inactive 
cytoophidia that provides buffering from metabolic fluctuations (enzyme inactivation by filament formation 
may provide a buffer against metabolic fluctuations, thus preventing accidental re-entry into the cell cycle).  
     Activity in the fibrillar (cytoophidic) state seems to be reduced. It’s not clear if this is due to blocking 
of the active site or constraint of conformational changes necessary for activity or if there’s simply a charge 
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interaction within the active site itself. Fibrillar disassembly presumably happens as rings dissociate. In the 
microscope images of Petrovska et al. (2014)101 the fibers are seen to “disappear” on the micron length 
scale with the reestablishment of well-fed conditions or increased pH. This suggests that the unbinding of 
fibers from each other as well as disassembly of the stacked ring filament structure happens in concert.  
     Gln1 cytoophidia in yeast, then, may be a storage depot for enzymes. This is seen in other enzymes like 
Ura7/Ura8, fibers of Gcd2, Gcd6, Gcd7, Gcn3 and Sui224. Other researchers have noticed that quiescence-
associated subcellular structures, such as proteasome storage granules and actin bodies, also form in a pH-
dependent manner and has concluded that the drop in intracellular pH is important for their formation137. 
The establishment of pH as an important messenger is furthered by work of Isome, et al.(2013)138 who show 
that the Gα subunit of G-proteins acts as a pH sensor. In these systems, signaling becomes more quiescent 
as the pH is dropped. This strongly reinforces the notion that intracellular pH changes serve as a global 
messenger to signal the depletion of energy during starvation and cellular quiescence133, 139. 
 
β-Glucosidase  
     A plastidal β-glucosidase from Avena sativa (oat) is activated during fungal infections. Antifungal 
precursors are stored in plant vacuoles and the enzyme activates these avenacosides by hydrolysis to form 
antifungal 26-desglucoavenacosides. The enzyme is a globular α/β barrel with two catalytic glutamic acid 
residues that act as nucleophiles or as an acid/base catalyst. β-glucosidase from oat (Avena sativa) 
hydrolyzes the β-glucoside avenacoside to C26-desgluco-avenacosides. This enzyme is nominally a 
homohexamer that hydrolyzes β1->4 glucose bonds; it also cleaves avenacosides as an antifungal defense. 
Antifungal precursors are stored in plant vacuoles and the enzyme activates these avenacosides by 
hydrolysis to form antifungal 26-desglucoavenacosides.  
     It has been known since 1965 that the oat β-glucosidase forms in vivo fibrils named “stromacenters”9. 
There are two isomers of oat β-glucosidase, As-Glu-1 and As-Glu-2. As-Glu-1 is sufficient to form 
filaments but can also induce fibrillar or filamentous formation with As-Glu-2 which normally forms a 
homodimer140. This filament resists pH and non-ionic detergents but can be disassembled with CaCl2141. 
Interestingly, Hevea β-glucosidase also forms long filamentous assemblies, but the enzyme in this species 
has not been studied extensively by higher resolution techniques or kinetic modeling9, 142. 
     Finite sized oligomers of oat β-glucosidase, trimers, hexamers and multimers, are seen by EM140-141. The 
protein is seen as a trimeric ring that dimerizes along the ring’s axis into hexamers. Larger ordered 
oligomers also stack along the axis of the ring into a filament (Fig. 7B-D). Through detailed reconstructions 
there seems to be a difference in the twist between neighboring trimers forming the “tunnel” housing the 
active sites. In the multimers, the twist between trimers is 38°, however in the non-filamented hexamers 
this is 60°. The smaller twist seems to result in smaller side fenestrations presumably changing access to 
the active site. This may explain both the reduced KM and kcat, since a caging effect may increase binding 
affinity to both substrates and products141. In addition, the kcat/KM of the multimers (i.e. filament) is twice 
that of the hexamer141. Hence, the caging effect may result in increased substrate discrimination, such as in 
preference for avenacoside substrates over other kinds of β-glucosides. Alternatively, or in addition, the 
physiological role of filamentation may be to create a strongly localized concentration gradient of antifungal 
product near the formation of the fibers of assembled filaments.  
 
Hydrogen-Dependent CO2 Reductase (HDCR) 
     The interconversion of CO2 and formic acid is an important reaction in bacteria, and enzymes catalyzing 
the oxidation of formic acid to CO2, and concomitant reduction of protons to molecular hydrogen have been 
known for decades143-144. However, only relatively recent has an enzyme capable of the reverse been 
characterized. This enzyme utilizes molecular hydrogen as electron donor for the reversible reduction of 
CO2 (the first reaction of the acetyl-CoA or Wood-Ljungdahl pathway) and has been named the hydrogen-
dependent CO2 reductase (HDCR)(Fig. 8A). It derives from an acetogenic bacterium, Acetobacterium 
woodii145. This pathway is utilized for carbon fixation as well as energy conservation145-147. Reduction of 
CO2 is also of interest in biotechnological applications such as removal of CO2 from the atmosphere, 
hydrogen storage, and hydrogen production. 
     HDCR is composed of four subunits in equal stoichiometry and forms filaments with increased 
enzymatic activity at concentrations of 0.05 mg/ml and higher, and in the presence of divalent cations148. 
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The lengths of the filaments are varied and can be more than 0.1 micron in length but with apparent bending 
indicating flexibility (Fig. 8B)148. Their formation is reversible and dependent on only the presence of 
divalent cations (e.g. Mg2+, Mn2+, and Ca2+) at concentrations of 2-20 mM148. The width of the filaments is 
10-15 nm, with an apparent helical structure148, however no three-dimensional analyses or higher resolution 
structures of the filament, or enzyme protomers has been reported. 
     Light scattering studies showed that the formation of polymers/filaments follows a first order process 
complete after 500 s, but with a fast initial jump148. Enzyme activity assays indicate that the polymeric form 
is more active by approximately 2-fold than the non-polymerized form148. Hence authors speculate that 
filamentation may be a regulatory mechanism to activate HDCR. Alternatively, it could stabilize the 
enzyme, regulate its degradation, or act as a scaffold for other enzymes, making use of close proximity for 
electron tunneling between iron-sulfur clusters of adjacent enzymes. Finally, it may serve to protect the 
iron-sulfur clusters from oxidative damage148. 
 
Nitrilase 
     Nitrilases are a family of enzymes that convert nitriles to the corresponding acid and ammonia (Fig. 
9A), and occasionally release an amide product (Fernandes et al. (2006)149, Pace & Brenner (2001)150). The 
majority of known enzymes are from bacteria, fungi, and plants. The enzyme composition is homodimeric 
with a αββα- αββα sandwich fold and an active site containing four positionally conserved residues: Cys, 
Glu, Glu and Lys. Nitrilases are attractive biocatalysts for the production of fine chemicals and 
pharmaceutical intermediates and also are used in the treatment of toxic industrial effluent and cyanide 
remediation. Nitrilases have been visualized as dimers, tetramers, hexamers, octamers, tetradecamers, 
octadecamers, and variable length helices, all with the same basic dimer interface, and was known since 
1977 to form large aggregates upon activation10-11. Self-assemblies are also visible in cells. Cutler & 
Somerville (2005)21 found GFP labeled Nitrilase I in Arabidopsis to form “aggregates” in cells following 
wounding and just prior to cell death (Fig. 9B). One function of nitrilases in vivo may be in detoxification, 
hence why these self-assemblies (which likely contain activated nitrilases) form upon wounding with 
herbicides. Negative stain electron microscopy shows the fine structure of activated, self-associated 
nitrilase enzymes as short spirals consisting of 8 to 22 subunits or long filaments (Fig. 9C)34, 151-154. These 
show a left-handed spiral with about 4-5 copies of the dimer per turn (Fig. 9D-F). Nagasawa et al (2000)155 
show that the activity of a nitrilase increased with formation of large aggregates from inactive homodimers 
(presumably the helical filaments). This aggregation could be induced by addition of benzonitrile, as well 
as the presence of salts and organic solvents (the best conditions were 10% saturated ammonium sulfate 
and 50% (v/v) glycerol, and by preincubation at increased temperatures or enzyme concentrations). Thuku 
et al (2007)152 found that the helical filamentous form could be formed by truncation of the C-terminal 39 
amino acid residues, perhaps indicating their involvement in regulating activation of the enzyme via helical 
filament formation. Interestingly, Woodward et al (2008)34 found that the substrate specificity of plant 
nitrilase complexes is affected by the helical twist of its filamentous state. Previously, attempts to swap 
specificities between nitrilase enzymes by swapping active site residues failed. However, helical twist and 
substrate size were found to be correlated among different nitrilase enzymes, and when binding pocket 
residues are exchanged between two nitrilases that show the same twist but different specificities, their 
specificities could be swapped. Modifying nitrilase helical twist, by either exchanging an interface residue 
or by imposing a different twist without altering any binding pocket residues, changes substrate preference. 
This is significant, as it shows that one function of filament formation is in determining substrate specificity 
among evolutionarily related enzymes (Fig. 9G). In addition, Thuku et al. (2009)156 speculate that helix 
could forms docking sites for other associated enzymes and that the central hole channels substrates and 
products. 
 
CoA-Dependent acetaldehyde and alcohol dehydrogenase (AdhE) 
     The AdhE enzyme is type of enzyme is found only in bacteria and photosynthesizing unicellular 
organisms. AdhE catalyzes the conversion of an acyl-coenzyme A to an alcohol via an aldehyde 
intermediate, which is coupled to the oxidation of two NADH molecules to maintain the NAD+ pool during 
fermentative metabolism (Fig. 10A). AdhE from Escherichia coli is a homopolymer of 96-kDa subunits 
harboring three Fe2+-dependent catalytic functions: acetaldehyde-CoA dehydrogenase, alcohol 
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dehydrogenase, and pyruvate formatelyase (PFL) deactivase. AdhE forms helical structures in cells (as well 
as in vitro) call “spiralosomes”. Spiralosomes were first identified by Kawata, et al. (1975)157 in 
Lactobacillus fermti F-4, but have been identified in several bacterial species since (see Laurenceau et al. 
(2015)158)(Fig. 10B). Having confirmed the identity of spiralosomes as composed of the enzyme AdhE, 
Kessler et al. (1992)22 describe their structure as a left-handed helical assembly of 20-60 subunits in rods 
of 45-120 nm in length (see Fig. 10C-D, from Laurenceau et al. (2015)158). They also show that subunit 
packing is widened along the helix axis when Fe2+ and NAD are present, which is accompanied by a change 
in width and pitch consistent with opening and stretching of the helix. Extance et al. (2013)159 purified 
recombinant Geobacillus AdhE and found it to form large assemblies refractory to crystallization. 
Crystallization of the ADH domain however was successful. By combining this structure with a homology 
model of AldDH they were able to propose a molecular model for the AdhE spiralosome (Fig. 10E). This 
model has 7 copies per turn with right handed helical geometry. Though it is not known what effect on 
enzyme activity this structure has, or if its structure is modulated in the cell, Extance et al. (2013)159 propose 
that it may enhance catalytic efficiency through substrate channeling of the reactive acetaldehyde 
intermediate, or alternatively, provide some stabilization of the protein. Kessler et al. (1992)22 hypothesize 
that the two forms visualized in their study represent the inactive, closed helical form, and the open, active 
form. 
 
 Glutamate dehydrogenase 
    Glutamate dehydrogenase (GDH, EC 1.4.1.2) is found in all living organisms and catalyzes the reversible 
oxidative deamination of L-glutamate to 2-oxoglutarate using NAD(P)+ as a coenzyme160 (Fig. 11A). In 
bacteria, the ammonia produced by GDH is assimilated to amino acids via glutamate and 
aminotransferases161. In plants, the enzyme can work in either direction depending on environment and 
stress162-163. Transgenic plants expressing microbial GDHs are improved in tolerance to herbicide, water 
deficit, and pathogen infections164. GDH from animals, but not other kingdoms, is allosterically regulated 
by a wide array of ligands165-171. Mammals encode two important GDHs, GLUD1 and GLUD2. GLUD1 is 
a mitochondrial matrix enzyme and plays a key role in nitrogen and glutamate metabolism and 
energy homeostasis. It is allosterically activated by ADP and inhibited by GTP and ATP. 
This dehydrogenase is expressed at high levels in liver, brain, pancreas and kidney, but not in muscle. In 
the pancreatic cells, GLUD1 is thought to be involved in insulin secretion mechanisms. In nervous tissue, 
where glutamate is present in concentrations higher than in the other tissues, GLUD1 appears to function 
in both the synthesis and the catabolism of glutamate and perhaps in ammonia detoxification. Two clinical 
conditions are associated with mutations in GLUD1: familial hyperinsulinism, characterized by 
hypoglycemia that ranges from a severe neonatal-onset, difficult to manage disease to a childhood onset 
disease with mild symptoms and difficult todiagnose hypoglycemia, and hyperammonemia/ 
hyperinsulinism, associated with mild to moderate hyperammonemia and with relatively mild, late-onset 
hypoglycemia172-173. These mutations affect regulation by GTP, causing failure to be inhibited by GTP. It’s 
link to insulin has made it a target for drug discovery for activators to increase insulin secretion in patients 
with diabetes174-176.  GLUD2 is localized to the mitochondrion and acts as a homohexamer to recycle 
glutamate during neurotransmission177. 
     Over 60 years ago, GDH purified from bovine liver was shown to form polymers in vitro. Olson & 
Anfinsen (1952)178 used sedimentation equilibrium to show it behaved anomalously, sedimenting at much 
larger molecular weights than expected.  Eisenberg & Reisler (1971)12 used light scattering to show 
evidence of polymerization. Huang & Frieden (1972)13 showed how ligands affect polymerization; GTP, a 
known inhibitor, causes depolymerization, and ADP, a known activator, can mitigate this effect13. Josephs 
& Borisy (1972)14 investigated the structure of assemblies of glutamic dehydrogenase and found that they 
formed linear polymers that further assembled into a helical tube, with 4 linear chains lining the tube (Fig. 
11B). Each linear polymer chain was found to be inclined to the tube axis at an angle of 28.5°±1.5°, with a 
pitch of ~800Å, with 9-9.3 molecules per turn. However, at least 3 variants of this geometry were also 
found. Zeiri & Reisler (1978)15 studied the catalytic activity of the polymers, although the relationship 
between them remained unclear. It is now known that the catalytically active form of GDH is a 
homohexamer of composed of six 54 kD subunits179-181, which can also associate further into filaments180-
182. Binding of leucine, ADP, succinyl-CoA, or BCH to the allosteric sites increases GDH enzyme activity 
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and polymerization of its polypeptide chain, while binding of GTP or palmitoyl-CoA to these sites 
decreases GDH enzyme activity and causes dissociation of the polypeptide chains from one another180-181, 
183. The activator and inhibitor sites are overlapping180-181, consequently, for example, leucine can displace 
GTP from the allosteric sites and activate the enzyme184. Despite all these studies, the role of GDH 
polymerization on enzyme regulation remains elusive. Finally, Shen et al. (2016)26 (re)discovered this 
phenomenon (although on a much larger scale and in vivo) using GFP labeled GDH, which occurred upon 
nutrient starvation (Fig. 11C), sparking interest in this phenomenon once again. 
 
Glutaminase 
     Glutaminase (EC 3.5.1.2), also known as L-glutamine amido hydrolase, catalyzes the cleavage of 
glutamine to ammonia and glutamate (Fig. 12A). Olsen and coworkers16 purified this enzyme from pig 
renal cortex and found it to consist of three forms: T, P and PB forms. After purification from pig kidney, 
the enzyme was in the P-B form. It was converted to the T form by dialysis overnight against 10 mM Tris-
HCl (pH 8.0) containing 3 mM EDTA, and recovered in the supernatant fraction following centrifugation 
at 80,000 g for 1 hour. The T form was converted to the P form by dialysis overnight against phosphate 
buffer, 50 mM (pH 8) containing 3 mM EDTA. The P form was further converted to the P-B form by 
addition of sodium borate, 15 mM (pH 8) to the enzyme in phosphate buffer. The T form (with a molecular 
weight estimated at 140 kD by sedimentation velocity, likely a dimer) is nonpolymerized and has low to no 
activity. The P-B form was found to be composed of long, double-stranded left-handed helical structures 
of various lengths, with a diameter of ~12 nm. The diameter of each of the two strands composing the helix 
is about 3 nm, and the length of each half-period along the helical axis is about 22 nm. Helices with 2-3 
turns, as well as 25-30 turns were observed. The P form also displayed helical structures in negative stain 
EM, but were much shorter than the PB form (produced by adding phosphate-borate buffer. Most were 4-
5 turns. 
     Since this early work many x-ray crystal structures of glutaminase have been revealed. DeLaBarre et al. 
(2011)185 published the first full length structure of human glutaminase (Fig. 12B). The structure shows a 
homotetramer with C4 symmetry. There is now considerable interest in glutaminase as a drug target to treat 
cancer because glutamine from blood can be converted to glutamate, which can be oxidized to α-
ketoglutarate to feed the TCA cycle or be used for the biosynthesis of several other amino acids and lipids186-
187. In humans, there are two distinct genes encoding glutaminase enzymes: GLS1 and GLS2. The GLS1 
enzyme is expressed at high levels in kidney and brain tissue. In the kidney, GLS1 is believed to maintain 
acid−base balance during metabolic acidosis187-188. 
     GLS2 is predominantly expressed in the liver where it provides nitrogen for the urea cycle. In the central 
nervous system, GLS1 activity is proposed to generate a significant amount of the total neuronal glutamate 
pool that in turn acts as an excitatory neurotransmitter189-191. GLS1 activity may therefore be essential for 
the optimal function of multiple central nervous system glutamate receptors and their downstream roles in 
both the normal and pathological brain. In the peripheral nervous system, GLS1 expression and activity in 
the dorsal root ganglia have been proposed to generate glutamate pools involved in inflammatory pain, 
suggesting a role for glutaminase inhibitors in the modulation of nociceptor function192. Finally, HIV 
associated dementia has been linked to upregulation of glutaminase activity and subsequent glutamate 
excitoxicity derived from HIV-infected macrophages193-194. 
    In 2013, Ferreira and coworkers195 published a detailed work describing the filamentous form of human 
glutaminase C (Fig. 12C-E). They propose it to be the most active form of the enzyme, composed of a right 
handed helical double-stranded helix with seven tetramer copies per turn per strand and interacting via the 
N-terminal domains (53±2 nm rise per turn, strand inclination of 25°, and an average width for a single 
strand of 6.6±0.7 nm, estimated resolution of model is 35 Å). They identify a lysine which becomes 
acetylated in vivo that down-regulates the enzyme by disrupting the filament. Previous models of enzyme 
activation involved promotion of inactive dimers into active tetramers by binding to phosphate, however, 
the inhibitor BPTES stabilizes the tetrameric form with a rigidly open gating loop at the active site. Ferreira 
et al. (2013) found that BPTES stabilizes the tetramer but disrupts the filamentous form, thereby explain 
the mechanism of inhibition as disruption of the filament. They also found that a mutation found in cancer 
cells (K325A) leads to enzyme much more prone to form filaments and therefore is hyper-activated.  
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β-lactamase-like protein (LACTB) 
     LACTB is a 55 kDa homolog of bacterial penicillin-binding proteins found in the intermembrane space 
of mitochondria of mammals196-197. Though its enzymatic activity is not known, homologues are serine 
proteases and all important motifs of such enzymes are preserved in LACTB 196. Studies have found a causal 
relationship between LACTB and obesity198. LACTB has been shown to polymerize into stable filaments 
both in vitro and in the mitochondrial intermembrane space (Fig. 13A). These may be important for 
submitochondrial organization and metabolon organization (Plianskyte (2009)199). Analysis of the filaments 
suggests that LACTB forms tetramers that further oligomerize into the observed polymers. In mitochondria, 
the LACTB filaments are found tethered to the inner membrane but spanning intracristal regions of the 
intermembrane space (Fig. 12B-C). The purpose of the filaments, or function of LACTB, are not currently 
known. 
 
2-Cys Peroxiredoxins (2CPrxs) 
     2-Cys Peroxiredoxins (2CPrxs) are thioredoxin-dependent peroxidases that catalyze the reduction of 
hydrogen peroxide using conserved active-site cysteine residues (Fig. 14A). These enzymes are found in 
archea, bacteria, and eukaryotes. Hydrogen peroxide produced in cells can be toxic although is also an 
important second messenger, hence its levels must be tightly controlled200-201. A functional switch from the 
detoxification/peroxiredoxin activity to ATP-independent molecular chaperone activity can be triggered by 
oxidative stress, site-specific phosphorylation, or high temperature in many 2CPrxs202(Fig. 14A). Both 
states have a role in human disease, from resistance to neurodegenerative disorders to host-pathogen 
interactions, up to the onset of cancer203-204. Foci of 2CPrx form in mouse epithelial cells under oxidative 
stress201 (Fig. 14B). 
     Reduced 2CPrx forms homodimers that can associate into toroidal decameric rings during the 
peroxiredoxin catalytic cycle (Fig. 14C)200, 205. Hyper-oxidation triggers stacking of decamers into 
filaments, which stabilizes the decameric structure (Fig. 14D), simulated by substitution of active site 
cysteines with serine (Fig. 14E-F)20082,188. The filaments appear as tubes with a central cavity that binds 
unfolded proteins206-207. Fig. 14G shows a theoretical model of filamentous 2CPrx based on x-ray crystal 
structures of the decameric ring forms of the enzyme207. Hence, 2CPrxs are also redox sensitive holdases, 
responding to redox stress by filament formation which then sequesters unfolded proteins and thereby 
prevents protein aggregation208.  
 
Ribonucleotide reductase (RNR) 
     Ribonucleotide reductases are responsible for all de novo biosynthesis of DNA precursors in nature by 
catalyzing the conversion of ribonucleotides to deoxyribonucleotides (Fig. 15A). Hence human RNRs are 
targets for anti-cancer drugs. Both class 1a (from human) and class 1b (from Bacillus subtilis) RNRs have 
been shown to form various oligomeric forms, including monomers, dimers, hexamers, and filaments209-
211(Fig. 15B). Punctate foci of RNR (both subunits, Rnr2 and Rnr4) were also discovered in yeast upon 
nutrient starvation25. The B. subtilis RNR is composed of NrdE and NrdF (α and β subunits, respectively), 
both being required for activity. The structures of various oligomeric states have been investigated for the 
class 1b RNR from B. subtilis by SAXS, x-ray crystallography, and cryo-EM210-211. Three distinct dimers 
(NrdE S type and I type dimers, and NrdF dimers) were characterized by x-ray crystallography (Fig. 
15C)210-211. Two filamentous forms were investigated using cryo-EM to 4.7-4.8 Å resolution (Fig. 15D-
E)210-211. Both occur under conditions of enzyme inhibition, namely high (100 µM) concentrations of 
dATP210-211. Considering only the NrdE subunit of RNR, a right-handed double helical filament is found 
which contains alternating dimeric interfaces (Fig. 15D, closeups of I and S type dimers shown in Fig. 
15Ci, iii). The presence of the NrdF dimers results in a filament with a single NrdE filament bound by NrdF 
dimers (Fig. 14E). A model for the allosteric regulation of RNR is shown in Figure 16. 
 
Recombinase A (RecA) 
     RecA (and its eukaryotic homologue Rad51) are responsible for strand exchange in homologous 
recombination, and process important for DNA repair, viral integration, and recombination of DNA 
segments between homologous DNAs as in meiosis212. These functions have roles in generating genetic 
diversity and preventing DNA damage that could otherwise result in diseases such as cancer. RecA forms 
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filaments upon binding to single stranded DNA and ATP, which then binds double stranded DNA, and 
through stretching the bound DNA, allows for homology searching by facilitating base pairing between the 
single and melted double stranded DNA duplex (Fig. 17A)213-214. Filament formation by RecA is highly 
cooperative. Hydrolysis of ATP releases the bound DNA and results in filament dissociation. RecA 
filaments have been characterized by electron microscopy (Fig. 17B) and x-ray crystallography (Fig. 17C). 
The x-ray crystal structure of short filaments of RecA (limited to 4-6 RecA protomers) bound to DNA 
(single stranded in one structure, double stranded in another) and a non-hydrolyzable ATP analogue have 
been solved to 2.8 and 3.15 Å214. These represent active filament structures, but the filament can also assume 
a separate, inactive structure, which was also characterized to 4.3 Å resolution214. In all cases, the filaments 
are right-handed with straight helical axes, ~6 RecA per turn and 94 Å pitch. The DNA is bound inside the 
helix formed by the RecA proteins, closer to the helical axis. The ATP analog binds at the interface between 
adjacent RecA protomers, explaining the ATP dependency of DNA binding and the dissocation from DNA 
upon ATP hydrolysis. The DNA is stretched globally, but adopts B-DNA-like conformation in the three 
nucleotides (or base pairs) bound to each RecA protomer, with stretching between. This stretching is 
thought to destabilize the donor duplex allowing local melting and sampling of base pairing by the original 
single stranded DNA214. 
 
Chromosomal replicator initiator protein (DnaA) 
     DnaA and its homologues in bacteria are required for the initiation of replication215-217. DnaA possesses 
a sequence specific DNA binding domain, which recognizes specific sequences in the bacterial origin, and 
is also a AAA+ ATPase which binds and hydrolyzes ATP. DnaA binds to the sequences at the origin and 
is responsible for inducing strand opening (Fig. 18A) at a nearby sequence, which then allows for loading 
of the replicative helicases DnaB (Fig. 18B). The crystal structure of DnaA bound to single stranded DNA 
shows a right handed helical filament that binds DNA on the interior of the spiral, near the helical axis218 
(Fig. 18C), reminiscent of the structure formed by RecA (Fig. 18D). Similar to the mechanism of RecA, 
the DNA is stretched from B-DNA helical parameters which is thought to be important for destabilization 
of the double helix. The ATPase domain is responsible for protein-protein interactions forming the spiral, 
as well as making non-sequence specific contacts to the DNA (Fig. 18B). The analogue of ATP found in 
the crystal structure binds at the interface between neighboring DnaA protomers, similar to ATP binding to 
RecA filaments. The helical filament contains 8 copies of the single chain DnaA protomer per turn (45° per 
protomer), with a pitch of 178 Å. Also like RecA, this filament is polar, meaning the two ends of the 
filament are not equivalent218. 
 
SgrAI restriction enzyme (SgrAI)   
     SgrAI is a type II restriction endonuclease from the bacterium Streptomyces griseus219. Restriction 
endonucleases protect their host cells from invading DNA, such as the bacterial viruses known as phage220. 
They are also considered to be coded by “selfish DNA” as their genes, as well as those for their cognate 
methyltransferases and possibly other related proteins have been shown to evolve through horizontal gene 
transfer from organism to organism221. They not only impart this benefit of innate immunity, but also other 
functions including genetic recombination, nutrition, and genome evolution among others222. Like most 
type II restriction endonucleases, SgrAI cleave particular sequences in double stranded DNA in a Mg2+ 
dependent reaction (Fig. 19A)219. The primary DNA recognition sequence of SgrAI is shown in Fig. 19B, 
CRCCGGYG, where R represents A or G and Y represents C or T219. SgrAI also cleaves a second type of 
site, secondary sites, with sequences CRCCGGGG or CRCCGGY(A or C or T)35. However, these are only 
cleaved if the primary site is also present, either on the same contiguous molecule of DNA, or at high 
concentrations35, 223-226. SgrAI also cleaves primary site DNA faster when there is more than one copy on 
the same contiguous DNA (or in high concentrations).  
     SgrAI forms filaments when bound to primary site DNA sequences17, 36-37, and its structure has been 
characterized to 3.5 Å resolution by helical reconstruction and cryo-electron microscopy39. The filament is 
a left-handed helix with approximately 4 copies of the SgrAI/DNA complex per turn (Fig. 19C). It is 
stabilized by protein-protein and protein-DNA interactions between neighboring SgrAI/DNA complexes. 
Compared to the structure of non-filamentous SgrAI, a ~10° rotation is found between the two chains of 
the SgrAI dimer39. In the structure of the non-filamentous state, determined by x-ray crystallography, one 
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of the two Mg2+ is displaced from its expected position, providing an explanation for the low DNA cleavage 
activity227-228. To accommodate the rotation between subunits in the filamentous conformation, many 
residues at the dimeric interface shift position which is hypothesized to stabilize a more optimal position of 
the misplaced Mg2+ (ref.39). 
     The working model for filament formation and activation of SgrAI is shown in Figure 19D39. SgrAI 
bound to DNA is in equilibrium between two conformations, a low activity T state and a high activity R 
state. Only the R state forms filaments. Filament formation in turn stabilizes the R state. In the absence of 
filament formation, the T state is favored, however the R state is populated sufficiently to self-assemble 
into filaments under certain conditions. When bound to the primary site, the R state is sampled sufficiently 
to form filaments if concentrations are also sufficient (Fig. 19E, top). When bound to the secondary site, 
the R state is less favored, and therefore filamentation is far less favored and secondary sites will not be 
cleaved (Fig. 19E, middle). Yet in the presence of filaments of SgrAI bound to the primary site, SgrAI 
bound to secondary sites will join, upon occasional sampling of the R state (Fig. 19E, lower). Structural 
studies suggest that the reason the R and T states differ energetically with the two sequences is due to 
sequence dependent DNA structural energetics. Base stacking is different in the R state conformation (in 
the filament), which is predicted to favor primary site sequences. Hence the origin of the differential DNA 
cleavage activity on the two types of sequences, primary and secondary, may originate in DNA structure 
and energy with filamentation serving as the means to detect this energy. In the filament, SgrAI cleaves 
both types of sites rapidly resulting in a 200 fold acceleration in the case of primary sites, 1000 fold in the 
case of secondary38. The expansion of DNA cleavage activity from primary to primary and secondary 
increases the number of cleavage sequences from 3 to 17. 
     Global kinetic modeling of filament association, dissociation, and DNA cleavage FRET reaction data 
indicate that the rate limiting step of the activated DNA cleavage reaction is filament association51-52. The 
second order rate constant is several orders of magnitude lower than diffusion limited (i.e. 105 M-1s-1). 
Hence to overcome this slow association rate constant, high concentrations (100 nM or greater) of 
SgrAI/DNA are needed (and in the R state conformation). In the cell, this limitation is overcome by the 
local concentration effect of recognition sequences on the same contiguous DNA50. Hence sites on the same 
DNA appear to be at a higher concentration, relative to each other, than they actually are in the cell and are 
more likely to form the filament, stabilize the activated conformation of SgrAI, and become cleaved. SgrAI 
bound to sites on separate DNA molecules are far less likely to associate into a filament, since 
concentrations of DNA in the cell are low (~3 nM). Primary sites in the host DNA are protected by 
methylation, but secondary sites are not. SgrAI will not bind to methylated primary sites, but does bind to 
the secondary sites tightly (nanomolar affinity). Invading DNA will contain both types of sites, 
unmethylated, and SgrAI in the cell binds both types. SgrAI bound to the primary sites induces the filament, 
which then draws in SgrAI bound to secondary sites, but only those on the same DNA molecule, owing to 
the local concentration effect50. This effect then is useful to focus or sequester enzyme activity on only 
substrates of interest, in this case the invading phage DNA and not the host DNA. 
     The global kinetic model also allowed simulations to be performed to predict SgrAI behavior under in 
vivo conditions50. Compared to a non-filament mechanism (Binary, with all the same rate constants but 
limited to an assembly of 2 enzymes, Fig. 20), the Filament-forming mechanism is superior in both speed 
(e.g. the rate of DNA cleavage), as well as the ability to sequester its damaging DNA cleavage activity on 
invading phage DNA (and away from host DNA, Figs. 19-20). Fig. 19A shows why the Filament 
mechanism is superior in speed over the Binary. The Filament mechanism has multiple ways for enzymes 
to assemble (Fig. 20A, left), whereas the Binary mechanism has only a single association configuration 
(Fig. 20A, center). Fig. 20B shows that the filament mechanism is superior to the Binary mechanism in 
cleavage of secondary sites (golden boxes, Fig. 20B), because no competition occurs between enzymes 
bound to the two types of sites. SgrAI bound to primary sites (blue boxes, Fig. 20B) induce filament 
formation, and SgrAI bound to secondary sites (gold boxes, Fig. 20B) join, leading to rapid DNA cleavage 
of all sites (Fig. 20B, upper). In the case of the Binary mechanism, association of enzyme bound to primary 
sites is preferred (Fig. 20B, lower), and outcompete association with secondary site bound enzymes, and 
are therefore cleaved far slower than in the Filament mechanism (compare red to green line, Fig. 20B, 
right). 
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     The Filament mechanism is also superior in sequestering enzyme activity (Fig. 21). In this figure, the in 
vivo role of SgrAI is depicted (Fig. 21A-C). SgrAI binds to primary and secondary sites on the phage DNA 
(Fig. 21A) and form the filament with activated DNA cleavage (Fig. 21B). However, due to the slow 
association rate constant of enzymes into the filament (i.e. 105 M-1s-1), and the intrinsically low 
concentration of DNA in the cell (estimated at 3 nM), but high local concentration of SgrAI on the same 
contiguous DNA (estimated >300 times higher50), SgrAI bound to secondary sites on the host DNA (blue 
arrow, Fig. 21B) do not assemble into the filaments (rate of association = 105 M-1s-1 * 3 nM * 3 nM = 0.0009 
nM/s), while those on the same contiguous DNA as the primary site (i.e. the phage DNA, red arrow, Fig. 
21B) do (rate of association = 105 M-1s-1 * 1 µM * 1µM = 100 nM/s). Hence, secondary sites on the host 
DNA, which are not methylated by the SgrAI methyltransferase, are largely protected from damaging DNA 
cleavage. Concurrently, secondary sites on the phage are cleaved, which is expected to increase the 
effectiveness against phage transcription and replication (Fig. 21C). Simulations performed with the two 
mechanisms, having identical rate constants, show this effect (Fig. 21D-E). Cleavage on the host is 
simulated with DNA concentrations of 3 nM, while that on the phage is estimated at 1 µM, the estimated 
local concentration between primary and secondary sites on the same contiguous DNA, based on average 
expected distances between sites50. Both mechanisms effectively sequester their cleavage activity on the 
phage DNA, because of the slow association rate constants of enzymes into the assembly (Filaments or 
Binary assemblies) and the low concentrations of DNA in the cell (see “Cleavage on host DNA” compared 
to “Cleavage of phage DNA”, Fig. 21D). However, the Filament mechanism is faster (compare red to green 
line, “Cleavage of phage DNA”, Fig. 21D). Yet if speed is required, a faster rate of Binary assembly could 
instead be evolved, rather than a complicated Filament forming mechanism with a slow association step. 
Fig. 21E shows why the Filament mechanism is yet superior; when the association rate constant for the 
assembly of the Binary complex is increased so that its DNA cleavage rate matches that of the Filament 
mechanism (a 4.5-fold increase is necessary)(green solid line for “Cleavage of phage DNA”, Fig. 21E), 
much more cleavage of secondary sites on the host DNA is predicted (blue arrow, Fig. 21E). The reason 
for this loss of sequestration is due to the much higher association rate constant necessary so that the DNA 
cleavage rate of the Binary matches the speed of the Filament mechanism50.  
 
The unfolded protein response nuclease kinase (IRE1) 
     In eukaryotes, the vast majority of secretory and transmembrane proteins are folded in the endoplasmic 
reticulum (ER). Inositol requiring protein 1 or IRE1 (also known as Ire1) is a transmembrane ER protein 
that senses unfolded proteins in the ER229, and has both kinase and RNase (and splicing) enzymatic activities 
(Fig. 22A-B).  The luminal domain of IRE1 senses the unfolded proteins by binding directly to them, as 
well as through the release of BiP (a protein that also binds unfolded proteins). This results in the assembly 
of IRE1 into dimers and higher order assemblies18, 230-234, observed as foci in live imaging (Fig. 22C)18, 234-
236. The assembly of IRE1 also allows for auto-phosphorylation via its cytosolic kinase domain, and 
consequential activation of its RNase activity in the assemblies18 (Fig. 22D-F). The RNase activity has two 
consequences: nonconventional cytosolic mRNA splicing and regulated IRE1-dependent decay (RIDD)237. 
The splicing involves two cleavages followed by ligation (by a separate RNA ligase) at conserved 
recognition sequences in the pre-mRNA for the transcription factor XBP1 (in metazoans) or HAC1 (in S. 
cerevisiae)237. Cleaved exons are then ligated by tRNA ligase in the case of HAC1238 and RtcB for XBP1239 
generating the spliced form of HAC1 or XBP1 mRNA240. RIDD leads to decay of mRNAs241-243. 
XBP1/HAC1 drives a large transcriptional program to adjust the ER’s protein-folding capacity according 
to the protein folding load in the ER lumen238, 244-247. The UPR is activated in cancers, viral infections, as 
well as neurodegenerative, metabolic, and inflammatory diseases229, 248-249. 
     IRE1 engaged in RIDD must be coupled with mRNA degradation enzymes in order to prevent either 
translating or ligating cleavage products240. One report suggested that the two RNase activities, RIDD and 
splicing, were controlled by different protein oligomeric states, with splicing a result of the filamentous 
form, and RIDD the dimeric form240. Another suggests that the different outcomes following cleavage by 
IRE1 (ligation or degradation), have more to do with RNA sequence and structure, and perhaps cellular 
location of mRNAs250. mRNAs that are degraded via RIDD encode proteins to lessen the ER stress burden 
and in extreme cases initiate apoptosis. During the adaptive response, IRE1 conducts RIDD on mRNAs 
encoding ER translocating proteins to prevent further increases in protein-folding demand in the ER251. In 
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metazoans, RIDD reduces the load of ER client proteins through mRNA degradation and cleavage of 28S 
rRNA252, particularly of mRNA that is associated with the ER membrane241-243, 251, 253, Also in metazoans 
it’s been shown that 21% of RIDD substrates encode proteins associated with gene expression regulation 
that might also participate in the global decrease in protein production254, and that RIDD reduces the total 
protein influx into the ER by 15%243. 
     Mammals have two IRE1 paralogs, IRE1α and IRE1β. IRE1α is expressed ubiquitously and knockout 
mice exhibit embryonic lethality. IRE1β expression is restricted, and knockout mice are viable, therefore 
the α is thought to be more important237. The two IRE1 modalities (splicing and RIDD) co-exist in metazoan 
cells241-242, 255, yet are evolutionarily separated in the two yeast species, S. cerevisiae and S. pombe. S. 
cerevisiae IRE1 has splicing, but no RIDD243, 256, while S. pombe IRE1 has RIDD but no splicing243. 
Mammalian IRE1α is more efficient in XBP1 mRNA splicing, while IRE1β prefers to cleave (leading to 
degradation) ribosomal RNA252, 257-258.  
     If attempts to restore ER homeostasis fail, IRE1 activates apoptosis through RIDD251, 259, degrading 
mRNA for UPR target genes and miRNAs that are anti-Casp2237. The latter results in upregulation of Casp2, 
a proapoptotic protease essential for the execution of apoptosis259. Therefore, IRE1α is a molecular switch 
and apoptosis executioner during ER stress237. 
     X-ray crystal structures of the luminal and cytosolic IRE1 have been reported. Those of the luminal 
domain show the basis for their signal dependent (i.e. unfolded protein binding) 
dimerization/oligomerization for S. cerevisiae233 and human260. Structures of the cytosolic domain have 
been solved in dimeric forms (yeast261 and human262), as well as a filamentous form of yeast IRE118. The 
yeast dimeric structure shows the kinase domain dimerizing back-to-back, which places the kinase active 
sites too far apart for auto-phosphorylation. However, a dimeric structure of the unphosphorylated human 
IRE1 shows face-to-face orientation of kinase domains, well positioned to autophosphorylate262. The 
authors interpret this structure as an early state, prior to phosphorylation, afterwhich the dimer assumes the 
back-to-back orientation that activates the RNase activity. The filament structure shows the S. cerevisiae 
IRE1 cytosolic domains in complex with a kinase inhibitor, which is a potent activator for the IRE1 
RNase18. The oligomeric structure positions the kinase domains perfectly for autophosphorylation and 
orders the RNAse domain of each IRE1 protomer. The filament creates surface for RNA binding and 
positioning of the splice sites. The filament is a right-handed helical filament made by the addition of the 
back-to-back dimers, hence a run-on oligomer (Fig. 22F). Each dimer is separated by a 54.2° rotation, 
giving 7 dimers per turn.  It was found in the structure that 17 residues of the IRE1 cytosolic domain were 
phosphorylated, which must have occurred via autophosphorylation during expression in E. coli. The three 
phosphorylated residues important for IRE1 activation in vivo, Ser 840p, Ser 841p, Thr844p, are well 
resolved in the crystal structure18 and are ideally placed to help IRE1 oligomerization18.  
     The trans-autophosphorylation as well as binding to ADP contribute to activation of the RNase of 
IRE118. In the oligomeric structure, the RNase domains are ordered, unlike in the dimeric structures, and 
the ordering appears to be due to intermolecular interactions only found in the oligomer. The ordering of 
the RNase domain structure is expected to activate its enzymatic activity18. Binding of a cofactor occurs in 
the open state of IRE1 kinase, shifts the equilibrium from monomers towards multimers and provides an 
additional, phosphorylation independent level of positive modulation for the activating transition18. 
Oligomerization of the unphosphorylated IRE1 opens the kinase domain and positions it for trans 
autophosphorylation. ATP enters the opened kinase and phosphorylates the activation loop in trans to lock 
it in the oligomerization compatible open state and to introduce a phosphate-mediated salt bridge at the 
interface IF3c18. These events provide positive feedback for oligomer assembly18. Cofactor binding and 
phosphorylation enhance the self-association properties of IRE1, but neither is strictly required18. 
 
Casein kinase 2 (CK2) 
     CK2 or casein kinase 2 is a highly conserved serine/threonine kinase (Fig. 23A) that is crucial for cell 
viability and is involved in cellular processes such as cell cycle control, cellular differentiation, and 
proliferation, circadian rhythm, apoptosis, and gene expression263-264. Human CK2 is a heterotetrameric 
holoenzyme (α2/β2) composed of two catalytic alpha subunits attached to a central, regulatory dimer of β 
subunits. CK2α is constitutively active, and upon interaction with CK2β is remains active but its 
thermostability, substrate specificity, and ability to attach and penetrate cell membranes is altered. 
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Conventional kinase regulatory mechanisms such as phosphorylation, dephosphorylation, or second 
messenger binding are not observed for CK2265. Instead, regulation of enzyme activity is proposed to occur 
by controlling the oligomeric state of the enzyme266. A mixture of oligomeric species including 
heterotetramers, ring like oligomers, and linear polymers have been observed using electron microscopy, 
analytical ultracentrifugation and native mass spectrometry (Fig. 23B-C)  and found to vary as a function 
of ionic strength, polycations, Mg2+ concentration, pH, and temperature266-269. Enzyme activity is maximal 
under conditions favoring the ring-like structures, and decreases with dissociation into the heterotetramers 
or association into filaments266. CK2α without CK2β is constitutively active and does not form higher 
assemblies266. Crystal structures of CK2 show a circular trimeric oligomer (1JWH270, and 4DGL271) or linear 
polymers (4MD7-4MD9 and 4NH1272). Native mass spectrometry using ion-mobility mass spec and H/D 
exchange confirmed the mixture of oligomeric states including heterotetrameric protomers, tetrameric ring 
like structures, and linear polymers which are sensitive to ionic strength (with high ionic strength causing 
disruption of the higher order forms)269. The stoichiometry of the complex also changes with ionic strength 
(α1,β2)1 to (α2,β2)1 ratio increases with decreasing ammonium acetate concentration269. Formation of 
oligomers and aggregates was shown in cells using BRET (bioluminescent resonance energy transfer) and 
found to be non-static273. The CK2 binding protein alpha subunit of the heterotrimeric G-protein that 
stimulates adenylyl cyclase (Gas), as well as the polycationic compound polylysine. Gas, but not the CK2 
substrate β-arrestin2, reduced the BRET signal associated with aggregation of CK2273.  
 
Adenylate kinase (AK) 
     Adenylate kinase performs the reaction shown in Figure 24A, and is found in plants and bacteria. Wild 
and coworkers274 determined the crystal structure of AK from maize with an inhibitor (adenosine-
(5’)pentaphospho(5’)adenosine (Ap5A) and found that the 24.9 kDa enzyme crystallized in a manner that 
produced infinite, linear “proto-rods” composed of hexamers (Fig. 24B-D). Based on contact surface area 
arguments, the authors propose that this is more than merely crystallographic packing. The authors also 
argue that the enzyme must be inactive in this linear assembly due to closing of a “lid” domain that cuts off 
access to the active site, and this “lid” domain participates in close contacts within the rod. The function of 
the rod, proposed by Wild et al. (1997)274, is to store AK during nighttime, when photosynthesis is low and 
AK activity is not required. Water would also be released from the rod, which is required during the night 
for plants. Once daytime arrives, the AK enzymes may quickly disassemble and become active again, 
avoiding the need for synthesis of new enzymes. However, no further enzymological studies of the 
formation of rods in vivo, or the effect of rod formation on enzyme activity have been reported.  
 
Receptor-Interacting serine/threonine-protein kinases (RIP1/RIP3 kinases) 
     RIP1 and RIP3 are intracellular signaling Ser/Thr kinases (Fig. 25A) that play important roles in immune 
defense, cancer, and neurodegenerative diseases. RIP1 controls whether the pleiotropic cytokine TNFα 
induces NF-kB activation, apoptosis, or programmed necrosis275. Programmed necrosis involves formation 
of an assembly, the necrosome, with RIP3 with activated kinase activity276-278(Fig. 25B). The necrosome 
recruits MLKL (Mixed Kinase Domain Like protein), which is phosphorylated by RIPK3 and immediately 
translocates to lipid rafts inside the plasma membrane276, 279-280. This leads to the formation of pores in the 
membrane, allowing the sodium influx to increase and consequently also the osmotic pressure, which 
eventually causes cell membrane rupture276. Phosphorylation stabilizes the assembly, which is mainly 
formed via interactions between a short segment (5-6 residues) of each protein known as the RIP homotypic 
interaction motif (RHIM)281(brown rectangle in Fig. 25B). This motif is surrounded by unstructured regions 
but forms a cross-beta amyloid structure through self-association or association of RIP1 and RIP3 with each 
other281 (Fig. 25C). This association is critical for function of RIP1 and RIP3 kinases in programmed 
necrosis281. Amyloid is distinct in its structure and binding properties, with this amyloid shown to be 
composed of alternately stacked RIP1 and RIP3 RHIMS to form heterotypic beta sheets. Two such beta 
sheets bind together along a compact hydrophobic interface featuring an unusual ladder of alternating Ser 
(from RIP1) and Cys (from RIP3) residues282. EM shows filaments of RIP1/RIP3 with its globular domains 
(kinase on both and death domain on RIP1) extending outward from a core protease resistant amyloid 
filament, and these structures appear to also interact to form larger aggregates281 (Fig. 25D shows a filament 
of RIP1 and the RHIM of RIP3). These are also seen from RIP1/RIP3 complexes purified from cells 
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undergoing programmed necrosis, but not controls, where foci are seen (Fig. 25E). The amyloid is 
remarkably resistant to denaturation, requiring 150 mM NaOH to disrupt281. The RHIM, which mediates 
amyloid formation, is found in a growing number of signaling adaptors with crucial functions in cell death 
and innate immunity275. Amyloids are fibrous protein aggregates composed of cross-beta structures and 
associated with many neurodegenerative283 and infective prion diseases284. Amyloids can perform normal 
cellular functions, such as host interaction, hazard protection and memory storage283. The purpose of 
amyloid/fibril formation may be for feed-forward gain of function in which kinase activation and 
RIP1/RIP3 necrosome formation are mutually reinforcing281. Upon amyloid formation, 
transphosphorylation occurs which activates RIP1/RIP3281.  
 
Death Domain containing proteins that form filaments 
     Filament forming proteins are increasingly recognized as critical intermediaries in signaling pathways 
including those of innate immunity, necrosis, and apoptosis285-286. These pathways contain proteins which 
upon initial stimulation (such as binding to a pathogen associated molecule in the case of innate immunity) 
leads to filament nucleation, propagation, and recruitment of downstream effectors such as kinases, 
transcription factors, caspases, and interleukins. The subcellular structures involved in innate immunity are 
known as inflammasomes. Filaments are formed similarly, via the Death Domain (CARD, PYD, DED). 
Example proteins include RIG-I, MDA5, and MAVS)287-288, NOD1/NOD2 and RIP2289, TLRs, MyD88, 
IRAK2, and IRAK4290, NLRPs, ASC, and Caspase-1291-293, and Fas-FADD294. Not all are enzymes, but 
many contain protein kinase domains. Figure 26A shows foci formed by GFP labeled RIP2, a CARD 
domain containing kinase that functions in innate immunity. Figure 26B shows a negative stain EM image 
of RIP2-CARD. Figure 26C shows a model from a three-dimensional reconstruction of a filament 
composed of the PYD domain of ASC. Though the different filaments formed by death domain containing 
proteins share many common features, studies show that they can have different geometries, including 
different handedness291, 295. Figure 26D gives models for inflammasome assembly of two different innate 
immune pathways that involve filament formation by DD containing proteins. 
 
Target of Rapamycin Complex 1 (TORC1 ) 
     TOR is a eukaryotic serine/threonine kinase found in TORC1 and TORC2, and TORC1 has been found 
to form foci in cells (Fig. 27A) composed of hollow, helical, cylindrical assemblies (Fig. 27B-C) upon 
glucose starvation296. The kinase is inactive in this assembly, which forms at vacuoles, and is dependent on 
Rag GTPases for its assembly through some unknown process (Fig. 27D)296. Prouteau and colleagues 
suggest that this assembly, they call the TOROID, may have a function to inactivate an expensive 
multiprotein complex in a cost-effective way296. TORC1 functions as a nutrient/energy/redox sensor and 
controls protein synthesis. 
 
Enzymes shown to form foci, rods, or cytoophidia in cells, but assembly 
architecture not known 
Glutamate Synthase (Glt1 in yeast) 
     Glutamate synthase forms L-glutamate from L-glutamine and 2-oxoglutarate which is an alternative 
pathway to L-glutamate dehydrogenase for the biosynthesis of L-glutamate (Fig. 28A), and participates 
with glutamine synthetase in ammonia assimilation processes. The enzyme is specific for NADH, L-
glutamine and 2-oxoglutarate. Both Noree et al. (2010)24 (Fig. 28B) and Shen et al. (2016)26 found that this 
enzyme forms foci and large rod-like structures (i.e. cytoophidia) in yeast cells when attached to GFP (or 
an HA tag, Noree et al. (2010)24). Noree et al. (2010)24 performed a number of additional tests investigating 
the control of self-assembly formation, such as measuring the self-assemblies at different phases of cell 
growth (log-phase, diauxic, and saturation) and found similar self-assembly in all. Shen et al. (2016) found 
that self-assembly formation increased in diauxic and saturation in both quantity and length. Noree et al. 
(2010)24 found that the Glt1p self-assemblies did not colocalize with other self-assembly forming enzymes 
(Ura7p or Ura8p (both CTPS), Psaip (GDP-mannose pyrophosphorylase), Gcd2p (eIF2b-delta), Gcd6p 
(eIF2b-ε, Gcd7pg (eIF2B-β), Gcn3p(eIF2b-α) or Sui2p(eIF2-α)). Gltp1 self-assembly formation was also 
unaffected by known regulators of prion biogenesis (RNQ1 and HSP104), nutrient deprivation, carbon 
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source depletion, energy status of the cell (by addition of sodium azide), protein synthesis (by addition of 
cycloheximide), or low temperature24.  
     Shen et al. (2016)26 measured dynamics of Glt1p self-assembly formation and found that these structures 
are motile and located preferentially at the cell cortex. Some are highly dynamic, while others are relatively 
slow. Analysis of the dynamics indicates that the self-assemblies undergo sub-diffusion, i.e. random 
diffusion within confined areas that is not driven by motor proteins. 
 
Asparagine Synthetase 
     Asparagine Synthetase (paralogous yeast genes Asn1 and Asn2) catalyzes the synthesis of L-asparagine 
from L-aspartate and L-glutamine in an ATP-dependent reaction and is part of the asparagine biosynthetic 
pathway)(Fig. 28C). Shen et al. (2016)26 uncovered rod shaped self-assemblies formed by this enzyme 
(Fig. 28D), and that these self-assemblies grew on going from log-phase growth to diauxic and stationary. 
These enzymes can form self-assemblies structures in both the cytoplasm and nucleus26. 
     Zhang et al. (2018)297 also studied the self-assembly formation of asparagine synthetase in yeast, and 
found an increase in self-assembly formation with glucose deprivation. They also investigation 
colocalization of the two paralogs and found that they colocalize, and that self-assembly formation of Asn2 
is dependent on Asn1. Although forming distinct structures (i.e. cytoophidia), both asparagine synthetase 
and CTPS cytoophidia are found adjacent to one another in cells, suggesting a connection, possibly 
metabolic.  
 
Eukaryotic translational initiation factor (eIF2/2B) 
     Noree et al. (2010)24 found proteins of the eIF2/eIF2B genes (Gcd2 (eIF2B-δ), Gcd7 (eIF2B-β), Gcd6 
(eIF2B-ε), and Sui2 (eIF2-α), Gcn3 (eIF2B-α)) formed cellular self-assemblies resembling rods (with either 
GFP or HA tags). These authors also tested for colocalization, using representative subunits of eIF2 and 
eIF2B (Gcd2 or eIF2B-δ and Gcd7 or eIF2B-β) and found that these do not colocalize with other self-
assembly forming proteins (CTP synthase, glutamate synthase, GDP-mannose pyrophosphorylase) but do 
colocalize with each other (and Gcd6/eIF2B-ε)(Fig. 28E). They found that eIF2/2B self-assemblies are not 
affected by known regulators of prion biogenesis (RNQ1 or HSP104), declined somewhat in saturated 
cultures (although varied by type of subunit), were not affected by carbon source depletion, or sodium azide 
(affecting energy status of the cell), were affected by an inhibitor of protein synthesis (cyclohexamide)(see 
also Campbell et al. (2005)298), and were not affected by lowering the temperature to 0°C or addition of the 
kinase inhibitor staurasporine. Shen et al. (2016)26 confirmed the findings of Noree et al. (2010)24, and 
discovered self-assembly formation by an additional eIF2B subunit, Gcd2 (eIF2B-δ). The eukaryotic 
translation initiation factor eIF2 mediates the first step of translation, by binding to the initiator met-tRNA 
and GTP and recognizing the start codon in an mRNA (Dever et al. (1995)299). GTP is hydrolyzed by eIF2 
to GDP after association with the ribosome, which in turn initiates translation. Regeneration of the active, 
GTP bound form of eIF2 is performed by the nucleotide exchange factor (GEF) eIF2B. Therefore, self-
assembly formation by eIF2/eIF2B prevents it from doing its job, no doubt, which is initiation of translation. 
Confirming this, Nuske, et al. (2018)300 found that starvation induced acidification of the cytosol causes 
self-assembly of eIF2B (Gcn3/eIF2B-α) and downregulation of translation that is independent of the kinase 
Gcn2. 
 
GDP-mannose pyrophosphorylase (Psa1) 
     The yeast gene Psa1, or GDP-mannose pyrophosphroylase (reaction catalyzed by this enzyme shown in 
Fig. 28F) was found in Noree et al., (2010)24 and Shen, et al. (2016) to form self-assemblies in yeast cells 
during stationary phase (i.e. nutrient starvation)(Fig. 28G). Noree, et al. (2010)24 performed several 
additional tests and found that these self-assemblies were distinct from the others (Ura7p, Glt1p, and 
eIF2/2B) tested. Like Glt1p self-assemblies, the Psa1p self-assemblies were no affected by knockouts of 
prion formation requiring proteins RNQ1 and HSP104, nor were they affected by overexpression of 
HSP104. Self-assemblies of Psa1p were significantly increased as nutrient starvation increased. Carbon 
source depletion had no effect on Psa1p self-assemblies. They were induced by treatment with sodium azide 
(affecting energy status of the cell). Cyclohexamide, or reduction in temperature to 0°C had no effect, but 
addition of the kinase inhibitor staurosporine greatly increased the number of cells with self-assemblies.  
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Xanthene oxidase  
     Xanthene oxidase from mammals is important in purine catabolism and nitrogen metabolism (Fig. 29A). 
A report in 1987 (Angermuller et al. (1987)301) indicated that self-assemblies from of homotetrameric rings 
of this enzyme form in vitro. No studies have been reported of the effect on enzyme function, or formation 
of such structures in vivo. 
 
Purinosome 
     Enzymes comprising the “purinosome” are responsible for de novo synthesis of purines (Fig. 29B) and 
include: phosphoribosyl-pyrophosphate amidotransferase (PRPPAT, step 1, Fig. 29B), Trifunctional 
GART enzyme (GAR Tfase, steps 2-3 and step 5, Fig. 29B), FGAMS/PFAS enzyme (step 4, Fig. 29B), 
Bifunctional PAICS enzyme (steps 6-7, Fig. 29B), ADSL enzyme (steps 8, Fig. 29B), and Bifunctional 
ATIC enzyme (steps 9-10, Fig. 29B). These have been shown to form reversible cytoplasmic foci under 
purine starvation (HeLa cells111, Fig. 29C) and general nutrient starvation (yeast25, 112) as well as in the 
female germ line in Drosophila29. Narayanaswamy et al. (2009)25 showed that the foci formation by Ade4 
(i.e. (PRPPAT)) was stimulated by absence of adenine in growth media, and could be reversed upon the 
addition of adenine. Ade4 punctate body formation was inhibited by the addition of the protein translation 
inhibitor cycloheximide. These Ade34 foci did not colocalize with P-body marker proteins and only in a 
limited way with actin bodies.  
 
Pyruvate kinase 
     Pyruvate kinase in yeast (gene Cdc19) is involved in carbohydrate metabolism (Fig. 30A) and found to 
form reversible punctate foci in yeast under starvation conditions25, as well as glucose starvation, heat 
shock, and hypoxia33, 302. Pyruvate kinase also colocalizes with phosphofructokinase-1 (PFK) and fructose-
bisphosphate aldolase in the self-assemblies also called G-bodies33. Formation of the large assemblies is 
postulated to depend upon a low compositional complexity region (LCR) within Cdc19, as they are 
prevented by tetramer formation, which sequesters the LCR302. The tetrameric form is favored by binding 
to fructose 1,6-bisphosphate. Cdc19 aggregation appears to trigger its localization to stress granules and 
modulates their formation and dissolution. Reversible aggregation is thought to protect Cdc19 from stress-
induced degradation, thereby allowing the cell cycle restart after stress302. Addition of glucose causes rapid 
dissolution of the aggregates, and did not depend on protein synthesis (i.e. cycloheximide had no effect). 
The assemblies were also unaffected by inhibitors of the proteasome or vacuolar protein degradation. 
 
G-bodies 
     Enolase, (yeast-gene Eno2)(Fig. 30C, E) and fructose bisphosphate aldolase (yeast gene Fba1)(Fig. 
30D-E), as well as phosphofructokinase (yeast genes Pfk1 and Pfk2) and pyruvate kinase (see above), all 
part of carbohydrate metabolism, form assemblies known as G-bodies under hypoxic conditions33. G-bodies 
have also been shown to be composed of other glycolytic enzymes including phosphoglucose 
isomerase(yeast gene Pgi1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (yeast gene Tdh3), 
tetrameric phosphoglycerate mutase (yeast gene Gpm1), enolase I (yeast gene Eno1), synthase subunit of 
trehalose-6-P synthase/phosphatase complex (yeast gene Tps1), beta subunit of fatty acid synthetase  (yeast 
gene Fas1), alpha subunit of fatty acid synthetase (yeast gene Fas2), and heat shock proteins (yeast genes 
HSP70, Ssa1, and Ssa2)33. Proteosomal subunits were also found to localize near G-bodies33. G-bodies were 
found to be required for increased glycolytic demand, and are distinct from stress granules or P-bodies33. 
G-bodies form specifically from hypoxia, and not glucose deprivation (in fact their formation required 
glucose), nitrogen deprivation, or after being grown on a nonfermentable carbon source33. The intrinsically 
disordered region (IDR) of PFK1 was found to be important for its colocalization to G-bodies, suggestive 
of a similarity to factors contributing to other membraneless compartments such as stress granules and P-
bodies33. The AMP activated protein kinase Snf1 is also required for G-body formation33, 303. G-bodies also 
appear to depend on RNA, as treatment of cells with ribonucleases decreases their formation303, hence 
reminiscent again of stress granules and P-bodies33, 304.  
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Mps1/Polo kinases  
     MPS1 protein kinases are found widely, but not ubiquitously, in eukaryotes. This family of potentially 
dual-specific (threonine/tyrosine) protein kinases is among several that regulate a number of steps of 
mitosis. The most widely conserved MPS1 kinase functions involve activities at the kinetochore in both the 
chromosome attachment and the spindle checkpoint. MPS1 kinases also function at centrosomes. Beyond 
mitosis, MPS1 kinases have been implicated in development, cytokinesis, and several different signaling 
pathways. Polo kinases are serine/threonine kinases that participate in 3 metabolic pathways: cell cycle, cell 
cycle - yeast, and progesterone-mediated oocyte maturation. 
     Gilliland et al. (2009)305 report that Mps1 and Polo kinase localize to numerous self-assemblies in the 
ooplasm of prometaphase Drosophila oocytes. They first appear throughout the oocyte at the end of 
prophase and are disassembled after egg activation. The self-assemblies form reversibly in response to 
hypoxia (Fig. 30F). The return to identical positions suggests an unseen filamentous structure in the cell, 
yet the kinases did not colocalize with tubulin, actin, anillin, septin, or lamin306. The addition of collagenase 
prevents filament formation by the kinases, suggesting that the underlying filament is sensitive to this 
protease. Gilliland et al. (2009)305 hypothesize that the self-assemblies formed by Mps1 and Polo could 
serve in signaling, that absence of the kinases results in a signal throughout the oocyte (a surrogate 
kinetochore). 
 
D-Amino acid oxidase 
     DAO catalyzes the oxidation of D-amino acids to their corresponding imino acid (Fig. 30G). The 
enzyme is most active toward neutral D-amino acids, and not active toward acidic D-amino acids. One of 
its most important targets in mammals is D-serine in the central nervous system. By targeting this and other 
D-amino acids in vertebrates, DAO is important in detoxification. The role in microorganisms is slightly 
different, breaking down D-amino acids to generate energy307. In 1966, Antonini et al (1966)308 used light 
scattering to demonstrate polymerization of the protein in vitro. Lower pH and temperature, and higher 
chloride concentration, decreased this polymerization. Similarly, infinite self-association was also shown 
to best fit sedimentation and light-scattering data of DAO purified from pig kidney309-310. 
 
Additional self-assembly forming enzymes discovered in large-scale screens 
     18 additional enzymes, in addition to several discussed above, were uncovered in Narayanaswamy, et 
al. (2009)25 as forming punctate foci in yeast under nutrient starvation conditions (stationary growth phase). 
90% of the proteins identified as forming foci in the GFP screen were also found in pelleted fractions of 
cell lysate (without GFP tags), showing the behavior in the absence of GFP. All proteins listed in Tables 
1-2 as identified in the Narayanaswamy screen were found to reversibly associate into these foci and 
dissociate upon addition of nutrients.  
     Enzymes identified as forming cellular self-assemblies by Narayanaswamy, et al. (2009)25 and not 
discussed above include alanyl-tRNA synthetase,  Leucyl tRNA synthetase,  Cystathionine β-synthase, 
Trifunctional CAD enzyme, adenylosuccinate synthetase, alcohol dehydrogenase, UDP-Glucose-
pyrophosphorylase, sterol 3-β-glucosyltransferase, peptidyl-prolyl cis-trans isomerase, glutamine tRNA 
synthetase, histidine tRNA synthetase, Isoleucine tRNA synthetase, Protein kinase of the PAK/Ste20 
family, ribosome-associated molecular chaperones, ATPases, threonyl tRNA synthetase, trehalose-6-P 
synthase/phosphatase complex, γ-aminobutyrate (GABA) transaminase, valyl-tRNA synthetase, and serine 
hydroxymethyltransferase.  
     In addition to acetyl-CoA carboxylase, CTP synthase, GDP-mannose pyrophosphorylase, and glutamine 
synthetase described in sections above, 13 additional enzymes were also found by Noree, et al. (2010)25 to 
form self-assemblies and foci in cells upon nutrient starvation. These include 5-phospho-ribosyl-1(alpha)-
pyrophosphate synthetase, glutamine amidotransferase (GATase II), threonine aldolase, glycogen synthase 
, glycogen phosphorylase, aminolevulinate dehydratase, multifunctional enzyme containing 
phosphoribosyl-ATP pyrophosphatase; phosphoribosyl-AMP cyclohydrolase, and histidinol 
dehydrogenase activities, S-adenosylmethionine synthetase, disaggregase (ATPase), ATPase involved in 
protein folding and NLS-directed nuclear transport, HSP70 family ATP-binding protein, non-ATPase 
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regulatory subunit of the 26S proteasome, homoserine kinase (yeast gene Thr1, also Thayer, et al. (2014)), 
and glycogen debranching enzyme. Werner, et al. (2009)23 identified UDP-N-acetylmuramate-alanine 
ligase as a cellular self-assembly-former. Shen, et al. (2016)26 confirmed many of those previously 
discovered, and also identified thioredoxin peroxidase as forming self-assemblies. Suresh, et al. (2016) 
discovered that the fatty acid synthase complex (yeast genes Fas1 and Fas2) form distinct foci under 
starvation conditions, and that these contain active enzymes and are not substrates of quality control 
proteins such as Hsp104 and did not co-localize with self-assemblies of Ura7, Pre6, or Ade4. They were 
also reversible, dispersing in the presence of added nutrients. Finally, a protein of unknown function with 
glutathione-S-transferase domain (Drosophila gene Fax, for Failed axon connections (CPTI-002774)) was 
found to form foci in the developing oocyte (Lowe et al. (2014)29). 
  
Discussion  
Filaments vary in structure 
     Over twenty different enzymes are now confirmed to form linear self-assemblies, polymers, or helical 
filaments that have been structurally characterized by electron microscopy or x-ray crystallography (Table 
1). Very likely, these structures are present in a biological context (in vivo) as well as in vitro. Another 50 
more form self-assemblies in cells that resemble those formed by filament forming enzymes, but have yet 
to be structurally characterized in molecular detail and therefore are not yet confirmed to form filaments 
(Table 2). This review prioritized those self-assemblies that are known to be reversible - to distinguish from 
those assemblies formed by aggregates of misfolded proteins, though reversibility has not been tested in 
every case (see Table 2). Of those filament forming enzymes for which the structure is known at the 
molecular level, most form helices (about half of the known filaments are left-handed, half right-handed) 
and without polarity (either end is equivalent due to internal symmetry of the enzyme building block)(Table 
1). Four form double helical structures (glutaminase, ribonucleotide reductase, glucokinase, and Filament 
3 of acetyl-CoA carboxylase, Table 1). Three form an intermediate structure composed of a ring which 
then stacks linearly to create a filament (glutamine synthetase, β-glucosidase, and 2-cys peroxiredoxin). 
Adenylate kinase and casein kinase 2 form linear filaments, without any helical nature. The death domain 
(DD) containing proteins can form complicated filaments with different proteins assembling in a specific 
order. Finally, in some cases, the filaments have a large internal cavity and form hollow tubes (TORC1, β-
glucosidase, nitrilase, glutamate dehydrogenase, and 2-cys peroxiredoxin). Hence, filaments form in a wide 
array of structures. 
     Although we have made an effort to collate a comprehensive list of proteins found to form filaments or 
at least cellular self-assemblies, we have not included the additional proteins uncovered in screens of protein 
aggregation in response to heat stress or arsenic, because our interest is in enzyme regulation and these 
screens likely identify proteins undergoing irreversible aggregation due to misfolding. Although it should 
also be noted that many of those proteins found to form cellular self-assemblies under nutrient stress also 
are found in the heat shock (or arsenic) induced cellular aggregates as well30, 130, 311. We have also not 
covered the proteins found in a screen for prion-like assembly formation312, as these protein assemblies 
have several distinct biophysical features affecting their solubility, reversibility, and heritability. Further, 
many other proteins and enzymes can be found in RNA-rich self-assemblies such as P-bodies, stress 
granules, and other membraneless compartments that are not given in Table 2, with filament formation yet 
to be investigated304, 313-314. 
 
Effect of filamentation on enzyme activity  
     Perhaps counterintuitively, most of the enzymes known to be modulated in activity by filament 
formation are activated in the filamentous state (13 total including filaments 1 and 2 of ACC, human CTPS, 
IMPDH, β-glucosidase, CO2-reductase, nitrilase, glutaminase, SgrAI, IRE1, RecA, DnaA, RIP1/3 kinases, 
and death domain containing, Table 1). Six enzymes are known to be inhibited (ACC filament 3, 
glucokinase, bacterial CTPS, glutamine synthetase, ribonucleotide reductase, and TORC1, Table 1). 
IMPDH is also suspected of having an inactive filamentous state. The enzyme 2-cys peroxiredoxin shifts 
from peroxireductase activity in the non-filamentous state, to a chaperone in the filament form which is 
inactive in peroxireductase activity. Hence it is inactive in the dimeric state, but gains an entirely new 
activity in the filamentous state. In the case of LACTB, which has sequence homology with β-lactamases, 
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it is not actually known if it possesses any enzymatic activity, much less how such activity is modulated by 
filamentation. Bacterial CTPS is thought to possibly act in cell shape determination when filamented43. It 
is not yet known if PFK, AdhE, and glutamate dehydrogenase are activated in the filament form, but other 
considerations suggest that they may be activated because the filaments form under conditions of high 
demand in the cell or high concentrations of substrate (PFK75-76), filaments form under conditions where 
the enzyme is more active (glutamate dehydrogenase180-181, 183), or have active sites more accessible to 
substrates (AdhE22)(Table 1). CK2 and adenylate kinase may be inhibited in the filamentous state (Table 
1). For enzymes of Table 2, it is not known how their activity is affected by filament formation, but many 
form filaments under nutrient starvation conditions suggesting that they filament in order to store 
inactivated enzymes until needed. Alternatively, filamentation may activate enzymes under conditions of 
stress due to high demand (such as G-bodies composed of enolase, PFK, and/or fructose bisphosphate 
aldolase)33. 
 
Filamentation can change enzyme specificity 
     In only a few enzymes does the substrate specificity change when in the filament form. SgrAI, a 
sequence specific endonuclease, cleaves 17 different 8 bp DNA sequences in the filamentous site, but only 
3 in the non-filamentous state17, 35, 38. IRE1 may also have expanded substrate specificity when filamentous, 
cleaving other RNAs in addition to its canonical RNA substrate240. The enzyme 2-cys peroxiredoxin 
changes specificity and enzymatic activity when filamentous, changing from a peroxireductase to a 
chaperone200, 206. A change in specificity to smaller substrates, due to reduced access to active sites located 
within the central tunnel of a fenestrated tube, was suggested for β-glucosidase141. Nitrilases from different 
organisms assemble into filaments with different helical twists, which correlate with their exhibited 
substrate specificities315. Hence, although not changing within the same filament, the family of nitrilase 
enzymes show that filaments may evolve to fine-tune activity and specificity for particular cellular needs. 
 
Regulation of filament formation 
     Regulation of filament formation also varies. Enzyme filaments stimulated by their substrates (and 
which become activated) include human CTPS, nitrilases, SgrAI (which is also stimulated by its product), 
RecA, and DnaA (Table 1). In the case of PFK, it is not known but likely to be activated in the filament, 
because filament formation is stimulated by its substrate76. Filaments of glucokinase form in response to 
substrates ATP and glucose90, when the enzyme concentration is above a critical concentration (2 µM), but 
is inactivated in the filamentous form. 2-Cys peroxiredoxin is stimulated by its substrate, H2O2, to form 
filaments with a new activity (binding unfolded proteins) but which is inactive in peroxiredoxin activity202. 
Filaments forming in response to their enzymatic product include SgrAI (cleavage products of their primary 
recognition sites which stimulate the enzyme activity), glucokinase (inhibited in the filament), and bacterial 
CTPS (also inhibited as a consequence of filamentation)(Table 1). Many enzyme filaments form in 
response to another signal, including binding to allosteric effectors (PFK, ACC Filaments 1-2, IMPDH, 
ribonucleotide reductase and glutamate dehydrogenase), or ligands (CO2 reductase, IRE1 and many death 
domain containing proteins)(Table 1). At least two enzymes are known to form filaments as a result of 
phosphorylation (ACC filament 3 and 2-cys peroxiredoxin), one from protein binding (ACC Filament 3), 
and others in response to buffer components (nitrilase, glutaminase, glutamine synthetase, CO2 reductase, 
2-cys peroxiredoxin)(Table 1). Phosphorylation stabilizes IRE1 filaments, as does ADP binding18. Just as 
filaments are stimulated in response to environmental stimuli, they may also be induced to disassemble. 
Those disassembled by their products, direct or downstream, include glutamate dehydrogenase13, 15 and 
human CTPS98. Filament formation by ACC1 and ACC2 are reportedly inhibited by binding to SPOT14 
and MIG12 proteins70 (although another report suggests MIG12 stimulates filament formation20). Others 
are known to be disassembled by buffer components (pH for Gln1, CaCl2 for β-glucosidase9, 142, and high 
ionic strength for casein kinase266). 
 
Direct transformation from one type of filament to another 
     Some filamentous enzymes may be capable of responding to environmental conditions without 
dissociating and reassembling into a new filamentous structure. Instead, these remain filamentous but 
coordinately (or not) change conformation to active or inactive enzymatic activity. Three possible examples 
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of this have been described. First, ACC forms the Filament 1 type filament in the presence of citrate and 
when the enzyme is not phosphorylated. The addition of a product of a reaction downstream of ACC, 
palmitoyl-CoA, results in what appears to be an altered Filament 1, but which now is inactive, and is named 
Filament 271. However, it is not known for certain at this time if this transformation from the active Filament 
1 form to the inactive Filament 2 form occurs without dissociating into ACC protomers. The second 
example is IMPDH. ATP stabilizes both types of filaments which are composed of stacked octameric 
IMPDH enzymes. The octameric IMPDH enzyme has the appearance of a hollow sphere with openings on 
the sides presumably for substrate and product diffusion. The open form is stabilized in the presence of a 
cofactor for the reaction, NAD+, while the closed form is stabilized by a downstream product of the enzyme 
pathway, GTP. The closed form is likely inactive, due to lack of substrate access to the active site, while 
the open form is likely the active state. Both states, open and closed octamers, have been visualized within 
the same filament128. This may indicate less cooperativity in the filament, since both states coexist, but it 
also indicates that the filament can be sensitive and responsive to molecular signals without dissociating. 
The third example is AdhE. Upon addition of cofactors Fe2+ and NAD+, the filaments appear slimmer and 
more extended22. This indicates responsiveness of the filament to the environment, although transition from 
one filamentous form to the other was not strictly investigated, hence these two forms may have required 
dissociation and reassociation. Further investigations are needed. 
 
Enzymes that form more than one type of filament 
     Five enzymes were shown to form more than one type of filament. Two were discussed above, ACC 
and AdhE, and in addition, ACC forms a third type of filament that requires phosphorylation of the enzyme 
and binding of the BRCT domains of BRCA171. Further, ACC may also form yet additional filament types, 
as filamentation in vitro and in vivo has been shown to be stimulated by the protein MIG12, which appears 
to form a co-filament with ACC20. Ribonucleotide reductase also forms different filamentous forms, both 
inactive, but which differ in architecture (one is a double helix, the other is a single helix) and the presence 
or absence of a protein NrdF210-211. CTPS also forms two types of filaments, one active and one inactive. 
Although in this case it is not the same CTPS enzyme; instead it is CTPS from a bacterial source that forms 
an inactive enzyme filament32, and CTPS from human that forms an active enzyme filament98. The filaments 
have similarities in structure, in that they are formed by stacking the tetrameric CTPS, but differences in 
the conformation of the tetramer and hence also the interfaces between tetramers within the filaments. These 
two filaments appear to be representatives of the type of activation or inhibition that derives from 
stabilization of either the active or inactive conformation of the enzyme by contacts between adjacent 
enzymes within the filament. Finally, nitrilases from different organisms have been examined and found to 
differ in the helical twist between the enzyme protomers, as mentioned above315. Interestingly, this 
difference in twist correlates with substrate preference, and hence evolution may have modified the filament 
structure to fine tune enzymatic specificity. 
 
Morpheins 
     Some filament forming enzymes are also morpheins48. Morpheins are proteins which can form more 
than one type of oligomer, each having distinct enzymatic properties, and where conversion from one type 
to the other requires dissociation into a more fundamental building block under normal physiological 
conditions. The interconversion is also post-translational modification independent. The shifting between 
oligomeric states is controlled by binding to allosteric effectors. The classic example of a morpheein is 
porphobilinogen synthase316-319. As for filament forming enzymes, the filament being one oligomeric state, 
2-cys peroxiredoxin and ribonucleotide reductase fit the strict requirements of a morpheein.  Other 
enzymes, such as SgrAI, are related to the morpheein model in that a fundamental building block (the SgrAI 
dimer) is stimulated to form a different, more active oligomeric form (a filament). However, it is stimulated 
by is substrate and product, rather than a distinct allosteric effector. It also does not have a second 
oligomeric state beyond the fundamental building block.  
 
Biological roles and possible selective advantages of filament formation by enzymes 
     It is clear now that many enzymes form filaments and large self-assemblies, and for some the role and 
advantage of those structures are yet to be uncovered. Many have stimulated enzymatic activity in these 
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self-assemblies, yet others are reduced or inhibited, showing filament formation to be another layer of 
enzyme regulation. Why filaments and large self-assemblies are necessary rather than (or in addition to) 
other mechanisms is an important next question for researchers. It may be that formation of the filament 
enables more rapid, and more cooperative activation or inactivation of the enzyme, as has been suggested 
for SgrAI (rapid activation50) and E. coli CTPS (rapid inactivation96). Many enzymes regulated by filament 
formation control key steps in biochemical pathways, such as PFK, which may require the additional layer 
of regulation76. Why a filament and not a discrete oligomer, such as a dimer, tetramer, hexamer, etc. is 
formed may be due to the fact that evolving a filament requires the selection of changes that result in a 
single type of interface between protomers that can propagate without steric hindrance, vs. a discrete 
oligomer such as a dimer that would require evolving an interface with two-fold symmetry that occurs only 
once between protomers47. Evolving other discrete oligomers would require such interfaces to lead to a 
ring, to “close the ends”. Interestingly, such closed ring oligomers can themselves form filaments by 
stacking, as discussed above.  
     Various strategies for controlling enzyme activity by filament formation are found. One strategy is to 
evolve an interface between protomers that preferentially stabilizes one conformation of the enzyme, either 
the active or the inactive state. Hence, the filamented enzyme is locked in one conformation, and cannot 
access the other state. Such is proposed for several enzymes, including SgrAI, glucokinase, and the CTPS 
enzymes. In the ribonucleotide reductase filament, binding of a second protein (NrdF) to the filament 
formed by NrdE leads to an inter-subunit gap that is too large to allow for radical transfer, thereby 
inactivating the enzyme211. In adenylate kinase, the active site is blocked by the filament structure274. 
Another strategy, for activating an enzyme by filamentation, is to create active sites from multiple enzyme 
protomers within the filament, such as Filament 1 of ACC71, DnaA218, and RecA214. Alternatively, formation 
of an internal tunnel within a hollow filament can aid in channeling substrates and products to different 
active sites as proposed in AdhE159, and may be a central feature of G-bodies, purinosomes and other 
metabolically related structures. The internally located active sites in hollow filaments means that substrates 
and products must diffuse through gaps between protomers, which may allow for mechanisms of selectively 
of substrates, as suggested for nitrilases156 and β-glucosidase141. In addition, forming a large assembly in 
the cell could localize products of the enzymatic reaction to particular locations. This was suggested for 
several enzymes activated by filament formation, but also β-glucosidase, where the filamentous structures 
produce anti-fungals and are activated upon infection141.  Conversely, filament formation may sequester 
enzymes away from one another and their substrates, modulating metabolic flux.  
     The filaments may be necessary to bind large substrates, as in the case of DnaA, RecA, IRE1, nitrilases, 
and significantly, for altering substrate specificities, as in IRE1 which cleaves additional mRNAs using an 
activity known as RIDD upon filamentation, and SgrAI, which cleaves an additional 14 DNA sequences 
when in the filament form. Significantly, simulations of enzyme activity based on kinetic modeling indicate 
that the filamentation mechanism can act to sequester enzymatic activity on only a subset of available 
substrates50-52. For example, as a direct consequence of filament formation, the expansion of substrate 
specificity by SgrAI occurs only on DNA molecules containing the SgrAI primary recognition sequence. 
The filament takes advantage of the higher local concentration of different recognition sites present on the 
same molecule of DNA to induce filamentation and cleavage activity on the secondary site sequences on 
the same contiguous molecule of DNA. Though this could be accomplished by a finite, discrete oligomer, 
the filament has the advantage of also maximizing speed of enzyme activation as well50. Local concentration 
effects are easily possible on large multi-substrate molecules such as DNA, but such activity may also be 
possible wherever high concentrations of a preferred substrate occur, which can induce filament formation 
to act upon a second type of substrate. Hence the second type of substrate is acted upon only where the high 
local concentrations of the preferred substrate occurs (Fig. 31), which could result from the activity of 
nearby enzymes, or in particular compartments including phase separated assemblies (liquid separated 
droplets in cells often formed from RNA and proteins)45. 
     Some filaments appear capable of switching between active and inactive conformations in the same 
filament, such as ACC, AdhE, and IMPDH. The purpose of the filament may be for more rapid 
communication of a signal for activation or alternatively, for inactivation. In this case, it’s akin to a 
multimeric enzyme with a large degree of cooperativity. 
     The filaments and self-assemblies may be a way to store unneeded enzymes, to protect against 
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degradation, and to be rapidly redeployed upon, for example, reintroduction of nutrients to the environment 
without the need for new transcription and/or translation. Such has been suggested for the cytoophidia and 
foci formed upon nutrient starvation25, 101. Filament formation may also be used to protect active enzymes 
from degradation or oxidation, as has been suggested for CO2 reductase148 and AdhE159. 
     Buffering of enzymatic activity is another proposed role of enzyme filaments and self-assemblies. Active 
enzymes in the non-filamentous state can reach an equilibrium with the inactive, filamentous state and by 
modulation of the on and off rates of this equilibrium, different levels of active enzyme in the pool can be 
achieved, as proposed for bacterial CTPS97. Thus, the level of active enzyme in a cell can be easily 
maintained and adjusted as needed. In the case of glucokinase, active monomeric enzymes reach an 
equilibrium with those in the filaments (composed of inactivated glucokinase), thereby maintaining a 
constant concentration of active enzyme and creating an upper limit to the maximum enzyme activity. This 
protects the cells from sudden “surges” in glucokinase activity that could be toxic. Binding of proteins to 
the filament to stabilize it from dissociation, such as Filament 3 of ACC with the binding of BRCT171, 
could further regulate filament dissociation.  
     Another reason for filament formation by enzymes may be to control water activity. Formation of large 
complexes such as enzyme filaments reduces the available protein surface area, thereby significantly 
reducing the amount of water required for full hydration of the protein320. Trihalsoe-6-P forms self-
assemblies in cells in response to desiccation33. Adenylate kinase, found in plants, is thought to form 
filaments at night when the enzyme is not needed, to free up available water274.  
     Several enzymes gain additional functionality in the filament form. The enzyme 2-cys peroxiredoxin is 
a striking example which switches from a peroxiredoxin to a chaperone upon oxidative stress205. The 
enzyme functions to eliminate H2O2 at lower levels, but higher levels will induce greater oxidation and 
eventually the formation of a hollow filament capable of binding unfolded proteins in its interior. This type 
of chaperone activity is non-ATP dependent and termed “holdase” since it sequesters the unfolded proteins 
from one another to prevent their aggregation. CTPS from C. crescentas is another example, which 
regulates cell shape in its filamentous form19. Acting as a scaffold for the binding of other proteins and 
enzymes is another gain of function that has been suggested for many filament forming enzymes. Certainly 
the death domain (DD) containing proteins and RIP1/RIP3 kinases do this, allowing binding and activation 
of downstream effector enzymes such as kinases, proteases, and membrane pore forming proteins276, 279-280, 
293, 295. Relatedly, the filaments could be a signal themselves to the cell of the levels of metabolites or other 
environmental stimuli. In addition to the proteins and enzymes of innate immunity (DD and RIP1/RIP3 
kinases), this function has been proposed for IMPDH128 and the kinases Mps1 and Polo305. In addition, it 
was suggested for IRE1 that filament formation could prolong the signal induced by unfolded proteins since 
self-assembly is self-propagating and stabilizing via auto-phosphoryation18, similar to inflammasomes 
composed of RIP1/RIP3 kinases and also DD enzymes like RIP2281, 289.  
     Finally, a role for filamentation in sequestering enzymes to particular compartments, such as cytoplasm, 
nucleus, or the mother cell in dividing cells. This was proposed for IMPDH, since in Drosophila it acts also 
as a transcription factor121. Thayer et al. (2014)321 proposed sequestration upon cell division for 
homocysteine kinase. 
 
Unique features of SgrAI 
     The most defining and unusual characteristic of the SgrAI endonuclease is its ability to use filament 
formation to modulate its DNA sequence specificity in a very targeted way. It does this by using the DNA 
sequence of its recognition sequence to modulate the equilibrium between two conformational states, an 
inactive, non-filament forming state, and an activated, filament forming state39. Binding to its primary 
recognition sequences shifts this equilibrium to the active, filament forming state more than does binding 
to its secondary site sequence. Hence it is SgrAI bound to primary sites that will drive filament formation, 
although SgrAI bound to secondary site sequences will join filaments under particular conditions. Joining 
the filament leads to activation of SgrAI and rapid cleavage of the bound DNA. However, joining is limited 
by a very slow association rate constant51. To overcome this limitation, high concentrations of filament 
forming states are necessary. In the cell, this is accomplished by SgrAI binding to primary recognition 
sequences on the same DNA molecule, and the high local concentration therefore drives the association of 
these SgrAI into a filament. Primary sites on the host are methylated and will not be bound by SgrAI, but 
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invading DNA is not expected to have the same protection. Hence unmethylated primary sites on the phage 
DNA drive SgrAI to form filaments, which also recruit SgrAI bound to secondary site sequences on the 
same DNA. Secondary sites are not methylated on the host, and therefore are at risk of being cleaved by 
activated SgrAI. SgrAI binds to secondary sites but does not cleave them unless activated by recruitment 
into a filament. However, the slow association rate constant for their incorporation into the filament, and 
the low concentration of DNA in the cell, prevents their recruitment into the filament formed on the 
invading DNA. Only the high local concentration of SgrAI bound to secondary sites on the invading DNA 
can drive their incorporation into filaments formed by SgrAI bound to primary sites there50.  
     The computational model developed from the kinetic study of DNA cleavage by SgrAI also found that 
the filament mechanism imparted greater speed in product production, and with a greater ability to sequester 
its activity (between sites on invading and host DNA)50. The sequestration of activity derives from the slow 
association rate constant for filament formation. Association and dissociation rates of enzymes into and out 
of filaments to our knowledge have not been measured, with the exception of the observation in some 
limited cases of cytoophidia dynamics. It remains then to be seen how general or specific this particular but 
distinguishing property of the SgrAI system is. As for the property of rapid activation, the opposite, rapid 
and efficient inactivation, has been suggested for the bacterial CTPS system. A mutation in CTPS, E155K, 
eliminates the ability to form filaments, but also does not show the significant reduction in activity shown 
by wild type CTPS96, 109.  
     Some other unique features of the SgrAI system are also found, including filament formation being 
stimulated by both substrate and product (of the primary site sequence), participation of the substrate (and 
product) in stabilization of the filament via direct interactions with neighboring protomers, and the 
requirement to dissociate from the filament in order to release product17, 37-38, 50-52. We found that the 
dynamics of SgrAI enzymes into and out of the filament is sufficiently fast to prevent trapping of the 
product, despite this requirement. Many filamentous enzymes with smaller substrates and products would 
not have such barriers to product dissociation.  
     Only IRE1 may share the unique property of substrate specificity modulation via filament formation, 
since some evidence suggests that the filamentous form is more effective in RIDD, an activity which results 
in degradation of other mRNAs in addition to that which is spliced by IRE1243. SgrAI cleaves 14 additional 
(secondary site) DNA sequences in the filamentous state, but only 3 (primary sites) in the non-filamentous 
state. It does so by drawing SgrAI bound to secondary site DNA sequences into filaments formed by SgrAI 
bound to primary site, thereby activating SgrAI to cleave the secondary sites. Secondary sites will not 
induce SgrAI to form filaments. A somewhat similar situation is found with β-glucosidase, two isomeric 
forms of the enzyme are known, As-Glu1 and As-Glu2. As-Glu2 forms a homodimer, but will be drawn 
into filaments formed by As-Glu1140. However, both forms of the enzyme, as well as both states (filament 
and non filamentous) possess the same enzyme specificity. 
     As for the qualities of becoming activated in the filamentous state, thirteen or more enzymes share this 
property, however, quantification of exactly how much more active is lacking for most systems. For SgrAI, 
the observed rate constants for cleavage of primary DNA show a 200-fold increase under filament forming 
conditions compared to non-filament forming conditions, and for secondary site sequences, this number is 
1000-fold38. However, kinetic modeling found the rate constant for activated DNA cleavage in the 
filamentous state is 0.8 s-1, 480 times faster than the observed DNA cleavage rate constant of primary sites 
in the non-filamentous state, and nearly 4000 times faster than with secondary sites38, 52.  
     Finally, the issue of length and time scales of filament forming enzymes requires addressing. Table 1 
summarizes enzymes where the molecular structure of the filamentous state is known, but in many cases, 
it is also known that these enzymes form large assemblies in cells that must be composed of either 
assemblies of these filaments, or perhaps some other structure. Table 2 summarizes enzymes for which 
only the cellular assembly has been observed, but studies of the molecular details of the assemblies have 
not yet been performed, hence it is unknown if they form filaments at the nanoscale. In one case, electron 
microscopy of a cell showed the large assembly to be composed of layers of aligned filaments. One could 
imagine that this would be most efficient for the purposes of storing and protecting inactive enzymes. In 
other cases, the assemblies may have other geometries, perhaps less organized (networks) and more like 
gels45 (PFK, known to form filaments, also forms liquid-like droplets in cells322). This may allow substrates 
and products to diffuse in and out of the large-scale assembly/droplet, perhaps making use of local 
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concentration to alter enzyme specificity, as in the SgrAI case, but using phase separation to induce the 
high local concentrations. As for timescale, our studies show association/dissocation of SgrAI with rate 
constants of 3x105 M-1s-1 and 0.02 s-1, resulting in very fast (subsecond) association under optimal 
conditions and a half-life of the complex on the order of seconds52. The timescale of filaments and cellular 
assemblies is less well characterized, though studies of Mps1/Polo kinases show complete dissociation after 
30 minutes, and complete re-filamentation upon reintroduction of filament inducing conditions after another 
30 minutes305. 
 
Conclusions 
     In conclusion, nearly 80 enzymes have been shown to form some sort of self-assembly either in cells or 
in vitro. Of these, 23 have been characterized for their assembly structure. Structures vary from the less 
common linear filament and ring stacks, to more common helical filaments, either right or left-handed. 
Enzyme activity may be enhanced in the filament, or inhibited, and less commonly, altered in some form. 
Some enzymes form more than one type of filament each with unique enzyme activities. Beyond controlling 
enzyme activity, other functions such as scaffolding, controlling cell shape, and signaling have also been 
shown. In the case of SgrAI, a type II restriction endonuclease, studies show that filament formation 
provides a clever means to control DNA cleavage behavior onto only invading DNA. The existence of 
filaments in vivo, their regulation and activity, and the wide range of diversity in structure and complexity 
is an emerging phenomenon in our biophysical understanding of cell biology. In the coming years, as more 
studies on filament forming enzymes are performed, no doubt new and interesting purposes and advantages 
will be uncovered. 
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Figures 
 
 
 
 
 
Figure 1 Filamentation of acetyl-CoA carboxylase (ACC). A. Reactions catalyzed by ACC. B. Complex 
regulation of ACC function involving filamentation (a.k.a. polymerization), phosphorylation, BRCA1 
binding, and allosteric inhibition (adapted with permission from Hunkeler et al. (2018)71). C. Negative stain 
electron micrographs of three different filament forms of ACC (adapted with permission from Hunkeler et 
al. (2018)71). D. Roles of the three filament forms in regulating ACC activity (indicated by red or green 
circles) (adapted with permission from Hunkeler et al. (2018)71). E. GFP labeled ACC form cytoophidia 
(large self-assemblies) in yeast cells under nutrient starvation (adapted with permission from Shen et al. 
(2016)26) 
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Figure 2 Reactions and filament formation by phosphofructokinase-1 (PFK). A. Reaction catalyzed by 
PFK (EC 2.7.1.11 ). B. Negative stain EM image of PFKL (liver isoform of human PFK) filament. Bar 
represents 100 nm. Arrows identify “kinks” (adapted with permission from Webb et al. (2017)76). C. PFKL-
EGFP filaments in cells MTln3 cells following addition of 10 mM citrate using confocal microscopy 
showing punctae. Not such puncta were apparent before the addition of citrate (not shown)(adapted with 
permission from Webb et al. (2017)76). D. Three-dimensional reconstruction of PFKL filament (adapted 
with permission from Webb et al. (2017)76). E. Coordinates of the tetramer of the PFKP crystal structure 
fit into the three dimensional reconstruction (adapted with permission from Webb et al. (2017)76). F. 
Schematic of PFKL tetramer associations in PFKL filament (adapted with permission from Webb et al. 
(2017)76). G. Left, schematic showing two different associations of PFKL tetramers leading to either linear 
or kinked filaments. Right, schematic of linear and kinked filaments (adapted with permission from Webb 
et al. (2017)76). H. Left images, 2-D class averages and right images, reconstructions, for linear and kinked 
filaments (adapted with permission from Webb et al. (2017)76) 
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Figure 3 Reaction catalyzed and structures formed by glucokinase (Glk1). A. Reaction catalyzed by 
glucokinase (Glk1), phosphorylation of glucose using ATP. B. Fluorescence images of stationary phase 
Glk1-GFP before (left) and after (right) the addition of glucose bars are10 µm. (Adapted from Stoddard et 
al (2019)90). C. Negative-stain electron micrographs of Glk1 in the absence of ligands (left) or in saturating 
glucose and ATP (right). Scale bars are 50 nm. (Adapted from Stoddard et al (2019)90) D. Surface 
representation of Glk1 filaments derived from cryoEM structure. Yellow/orange represent copies of the 
monomeric enzyme on one strand, light and dark blue on the other strand. The double-stranded filament is 
antiparallel, with close contacts between enzymes in each strand, as well as between strands. (Adapted from 
Stoddard et al (2019)90) 
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Figure 4 Reaction catalyzed by, and filaments formed of, CTP Synthase (CTPS). A. Reaction catalyzed by 
CTPS (EC 6.3.4.2). B. Cytoophidia or large rod-like structures of GFP labeled self-assemblies observed in 
yeast under nutrient starvation conditions (adapted with permission from Noree et al. (2010)24). C. 
Filaments of ecCTPS formed by a mutant designed to for crosslinks to stabilize the filamentous structure 
viewed by negative stain EM. Line represents 200 nm (adapted with permission from Lynch et al. (2017)98). 
D. Filaments of human CTPS formed in the presence of UTP, ATP, and GTP. Bar represents 50 nm. 
(adapted with permission from Lynch et al. (2017)98). e. Models of CTPS filaments from human (left) and 
bacteria (right) based on single particle cryo-EM reconstructions and their relationship to the presence of 
substrates (UTP) and products (CTP)(adapted with permission from Lynch et al. (2017)98) 
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Figure 5 Reaction catalyzed and filaments formed by IMPDH. A. Reaction catalyzed by IMPDH (EC 
1.1.1.205)( adapted with permission from Hedstrom, (2009)117). B. Cytoophidia, or large rod and ring like 
structures, formed in HEK293 cells by GFP labeled IMPDH after introduction of the IMPDH inhibitor 
ribavirin (adapted with permission from Anthony et al. (2017)128). C. Negative stain EM micrograph of 
filamentous IMPDH induced with purified IMPDH in vitro with 5 mM NAD+ and 1 mM ATP (adapted 
with permission from Anthony et al. (2017)128). The scale bar represents 50 nm. D. Single particle 
reconstructions using cryo-EM images of filaments of IMPDH formed with either ATP and NAD+ (left) or 
ATP and GTP (right) (adapted with permission from Anthony et al. (2017)128). e. Model relating open (left) 
and collapsed (right) filaments of IMPDH (adapted with permission from Anthony et al. (2017)128) 
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Figure 6 Reactions catalyzed and structures formed by glutamine synthetase. A. Reaction catalyzed by 
glutamine synthetase (EC 3.5.1.2). B. mCherry labeled glutamine synthetase forms cytoophidia in yeast 
cells under nutrient starvation (adapted with permission from Petrovska et al. (2014)101). C. Asymmetric 
unit of x-ray crystal structure (PDB code 3FKY131) showing pentameric rings that stack head-to-tail to form 
a decamer, than further stacks with another decamer in the head-to-head fashion. D. Electron microscopy 
of glutamine synthetase cytoophidia in yeast cells showing stacked filamentous fine structure (adapted with 
permission from Petrovska et al. (2014)101). E. Negative stain EM of the constitutive cytoophidia forming 
mutant R23E of yeast glutamine synthetase showing filaments that appear to be composed of stacked rings. 
(adapted with permission from Petrovska et al. (2014)101) 
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Figure 7. Reaction catalyzed and filamentous structures formed by oat β-glucosidase. A. Reaction 
catalyzed by oat β-glucosidase (EC 3.2.1.21). B. Negative stain EM micrograph of filamentous oat β-
glucosidase (adapted with permission from Kim et al. (2005)141). C. Single particle reconstruction using 
cryo-EM images of oat β-glucosidase showing the filamentous form which forms from stacks of hexamers 
(themselves made of stacked trimeric rings). Scale bars are 20 nm (adapted with permission from Kim et 
al. (2005)141). Left, top view, middle and right, side views. D. Hexameric unit from filamentous form shown 
in C, with additional symmetry applied during refinement. Scale bars are 2 nm (adapted with permission 
from Kim et al. (2005)141). Left, top view, middle and right, side views 
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Figure 8. Reaction catalyzed and assemblies formed by A. woodii CO2 reductase. A. Enzyme reaction 
carried out by hydrogen dependent CO2 reductase (HDCR) from A. woodii. Electrons for CO2 reduction are 
either provided by the hydrogenase subunit HydA2, where hydrogen oxidation takes place, or by reduced 
ferredoxin (Fd). Electrons are delivered to the active site for CO2 reduction in FdhF2 via the electron-
transferring subunits HycB2/3. Fdh, formate dehydrogenase, Hyd, hydrogenase, CODH, CO 
dehydrogenase (adapted with permission from Schuchman et al. (2013)145). B. Negative stain EM 
micrograph of CO2 reductase showing filamentous assemblies (adapted with permission from Schuchman 
et al. (2016)148). Scale bar represents 100 nm. 
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Figure 9. Reactions catalyzed and structures formed by nitrilases. A. An example of one of the many 
reactions carried out by nitrilase superfamily members (EC 3.5.5.1). (adapted with permission from Pace 
& Brenner (2001)150.) B. In a plant cell, GFP labeled Nitrilase forms self-assemblies (green) around 
chloroplasts (red) following cell injury. Scale bars represent 10 microns (top) and 25 microns (bottom). 
(adapted with permission from Cutler et al. (2005)21). C. Negative stain EM micrograph of Capsella rubella 
nitrilase 2 filaments formed in vitro. Scale bar represents 50 nm (adapted with permission from Woodward 
et al. (2018)315). D. Single particle reconstruction of Capsella rubella nitrilase 2 from negative stain EM 
(adapted with permission from Woodward et al. (2018)315) E-F. Orthogonal views of model built from 
flexible fitting of the Rhodococcus rhodochrous nitrilase structure into the EM reconstruction (adapted with 
permission from Chan et al. (2011)323). G. Cartoons of two nitrilase structures (Bacillus pumilus CynD and 
Arabidopsis thaliana nitrilase 3)( adapted with permission from Woodward et al. (2018)315). 
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Figure 10. Reactions catalyzed and structures formed by AdhE. A. An example reaction carried out by 
AdhE (EC:1.2.1.10). This enzyme can follow the same pathway with longer aliphatic chains including 
proprionyl-CoA, valeryl-CoA, butyryl-CoA, and hexanoyl-CoA. B. Formation of helical structures in cells 
viewed using negative stain EM. Portion of a partially lysed cell found in the cytoplasmic membrane 
fraction obtained from L. casei Var. casei 1001. Fine spirals (S) are seen in a cluster within the degraded 
cytoplasm. Scale bar is 100 nm. (adapted with permission from Kawata, et al. (1975)157). C. Negative stain 
EM micrographs of immunopurified Streptococcus pneumoniae “spiralosomes”, helical structures formed 
by AdhE. (adapted with permission from Laurenceau et al. (2015)158). D. A representative class average of 
the S. pneumoniae spiralosome. Scale bar is 5 nm (adapted with permission from Laurenceau et al. 
(2015)158). E. Two views of a spiralosome model built with the x-ray crystal structure of G. 
thermoglucosidasius spirosome159. The color of the individual protomers alternate between grayscale and 
domain-coded color representation, and successive AdhE dimers alternate between ribbon and surface 
representation (adapted with permission from Laurenceau et al. (2015)158). 
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Figure 11. Reactions catalyzed and structures formed by glutaraldehyde dehydrogenase (GDH). A. 
Reaction catalyzed by glutamate dehydrogenase (EC 1.4.1.2). B. Helical tubes of bovine GDH in vitro by 
negative stain EM (adapted with permission from Josephs and Borisy (1972)14). C. GFP labeled GDH 
form a rod-like structure or “cytoophidia” in cells (yeast) under nutrient starvation conditions (adapted 
with permission from Shen et al. (2016)26).  
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Figure 12. Reaction catalyzed and structures formed from glutaminase. A. Reaction catalyzed by 
glutaminase (EC 3.5.1.2). B. Structure of full length human glutaminase bound to the inhibitory molecule 
BPTES (adapted with permission from DeLaBarre et al. (2011)185). C. Negative Stain TEM of crosslinked 
glutaminase filaments (scale bars represents 100 nm)(adapted with permission from Ferreira et al. 
(2013)195). D. A model of one of the two strands of the double helical glutaminase filaments (adapted with 
permission from Ferreira et al. (2013)195). E. A model of the double helical filament of glutaminase (adapted 
with permission from Ferreira et al. (2013)195). 
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Figure 13. A. Filaments of purified LACTB viewed by negative stain EM (adapted with permission from 
Plianskyte et al. (2009)199). B. Thin section of a rat liver mitochondrion with filaments in the cristal part of 
the intermembrane space. (adapted with permission from Plianskyte et al. (2009)199). C. Schematic of 
location of LACTB filaments in the intra-cristal part of the intermembrane space of mitochondria. IM, inner 
mitochondrial membrane, OM, outer mitochondrial membrane, IMS, intermembrane space, M, matrix. 
(adapted with permission from Plianskyte et al. (2009)199). 
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Figure 14. Reactions catalyzed and structures formed from 2-Cys peroxiredoxin (2CP). A. Under oxidant 
conditions, the sulfenic acid intermediate of the peroxidatic cysteine residue may be further oxidized to 
sulfinic acid. The reduction of the enzyme, which is most efficiently performed by NADPH-dependent 
thioredoxin reductase C (NTRC), is a pre-requisite for sulfenic acid formation and, thus, for overoxidation. 
Srx is able to catalyze the reversion of the overoxidized to the reduced form of the enzyme. Therefore, the 
redox status of chloroplast 2-Cys Prxs is highly dependent of NTRC and Srx. The quaternary structure of 
2-Cys Prxs determines the activity of these enzymes. In the reduced form the enzyme is a dimer and shows 
peroxidase activity; overoxidation as occurs in oxidative stress favors the formation of the decameric form, 
which lacks peroxidase activity, can stack into filaments, and shows chaperone activity.  (adapted with 
permission from Puerto-Galán et al. (2013)201). B. Synchronized C19 mouse epithelial cells treated with 
glucose oxidase then stained for 2CPrx. (adapted with permission from Phalen et al. (2006)324). C. Toroidal 
decamer of Schistosoma mansoni 2CPrx. (adapted with permission from Saccoccia et al. (2012)207). D. 
Negative stain EM micrograph of bovine CPrx showing stacked rings. (adapted with permission from 
Gourlay et al. (2003)325). E. Negative stain TEM of recombinant C48S mutant of CPrx from Schistosoma 
mansoni that results in constitutive chaperone activity (and constitutive filament formation)(adapted with 
permission from Angelucci et al. (2013)202). F. Negative stain EM micrograph of bovine C47S CPrx 
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showing filaments (adapted with permission from Gourlay et al. (2003)325). G. Theoretical model of 
filamentous 2CPrx from from stacked decameric rings. Cyan and red show alpha and beta structures, 
respectively, from subunits of each ring and their relative orientations (adapted with permission from 
Saccoccia et al. (2012)207. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. A. Reaction catalyzed by ribonucleotide reductase (EC 1.17.4.1). B. Negative stain TEM 
showing filaments of human RNR. Scale bar represents 50 nm (adapted with permission from Ando et al. 
(2016)209). C. X-ray crystallographic structures of B. subtilis RNR dimers. i. S-type dimer of NrdE (α 
subunit of RNR). ii. I-type dimer of NrdE (α subunit of RNR). iii. Dimer of NrdF (β subunit r RNR)(adapted 
with permission from Thomas et al. (2018)210). D. Cryo-EM structure of B. subtilis RNR filament of NrdE 
bound to dATP (adapted with permission from Thomas et al. (2018)210). E. Cryo-EM structure of B. subtilis 
RNR filament of NrdE and NrdF with dATP (adapted with permission from Thomas et al. (2018)210).  
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Figure 16. Model for allosteric regulation of B. subtilis RNR. Without nucleotides, NrdE is a monomer, 
but dAMP and dATP can bind the I-site and induce a partially inhibited I-dimer. Addition of specificity 
effectors (dATP, TTP, or dGTP) instead induces the monomer to form an S-dimer. When specificity 
effectors (including dATP) bind to the I-dimer, they induce formation of an inhibited double-helical NrdE 
filament composed of alternating S- and I-dimer interfaces. NrdF competes for the NrdE double-helical 
interface, and thus NrdF binding leads to the dissociation of the NrdE double-helix into an individual helical 
structure. Binding of NrdF to the NrdE filament leads to an inter-subunit gap that is too large to allow for 
radical transfer. Both the NrdE and NrdEF filaments are reversible by addition of ATP, which can displace 
dATP from the I-site and induce dissociation of the I-dimer interface. Finally, addition of NrdF to the S-
dimer leads to formation of an active but asymmetric α2β2 tetramer in which a hinge motion between the 
two subunits plays an important role in activity (adapted with permission from Thomas et al. (2018)210).  
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Figure 17. Reaction catalyzed and structures formed by RecA/Rad51. A. Reaction of DNA strand 
exchange catalyzed by RecA/Rad51. B. Negative stain electron micrograph of human Rad51 with single 
stranded DNA, ADP and AlF4 – (adapted with permission from Yu et al. (2001)326). C. Helical 
reconstruction of filament shown in B (adapted with permission from Yu et al. (2001)326).  D. X-ray crystal 
structure of E. coli RecA bound to single stranded DNA, ADP, and AlF4- (adapted with permission from 
Chen et al. (2008)214) . 
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Fig. 18. Reaction catalyzed and structures formed by E. coli DnaA. A. ATP dependent DNA duplex 
opening reaction catalyzed by DnaA. B. Filament formation by DnaA on the E. coli origin of replication 
results in strand separation facilitating replicative helicase loading (adapted with permission from Bleichert 
et al (2017)327). C. X-ray crystal structure of Aquifex aeolicus DnaA bound to single stranded DNA (adapted 
with permission from Duderstadt et al (2011)218). 
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Figure 19. Reactions catalyzed and structures formed by SgrAI. A-B. Cleavage (hydrolysis) of double 
stranded DNA catalyzed by SgrAI, a type II restriction endonuclease (EC:3.1.21.4). C. (Left) Filament 
formed by SgrAI bound to primary site DNA, also known as a run-on oligomer. (Right) Three different 
views of a single SgrAI/DNA complex, the basic building block of the run-on oligomer filament. C. 
Working model of activation via filament formation by SgrAI. D. Working model for expansion of DNA 
sequence specificity of SgrAI in recruiting SgrAI bound to secondary site DNA sequences (gold balls) by 
filaments formed by SgrAI bound to primary sites (blue balls). 
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Figure 20. The filament mechanism of SgrAI is superior to a non-filament, binary mechanism 
(forming a complex of 2 enzymes) in both speed and cleavage of secondary sites. A. The greater speed 
derives from multiple ways enzymes can associate in the filament (left, red arrows) compared to a finite, 
discrete, binary non-filament model (middle, green arrow). Simulations show the greater enzymatic activity 
of the filament mechanism (red) over the non-filament or binary model (green)(right). B. The filament 
mechanism is superior in cleavage of secondary sites as well, since these are out-competed compared to 
primary sites in the binary model (lower, green and gold arrows), but do not compete in the filament model 
as more enzymes can always add to either end (top, red arrow). 
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Figure 21. The filament mechanism is superior in sequestration of secondary site cleavage activity. 
A. SgrAI is inactive (grey) and binds to secondary sites (gold boxes) in the host DNA (right) and both 
primary (blue boxes) and secondary sites in the invading DNA. While bound to primary sites, SgrAI 
equilibrates between active and inactive states (partial purple color). B. SgrAI in the active conformation 
(purple) associates into a filament (red arrow), drawing in SgrAI bound to secondary sites, inducing their 
activation (purple color), and resulting in DNA cleavage. C. Both primary and secondary sites are cleaved 
on the invading DNA, but secondary sites on the host DNA are uncleaved (cyan arrow). D. Simulation 
using kinetic model derived from global data fitting showing the superior DNA cleavage kinetics of the 
filament mechanism (red solid line) over the non-filamentous binary model (green solid line). Cleavage of 
the host DNA is minimal in both models (thicker dotted lines). E. Simulation with increased association 
rate constant in the binary model only such that its DNA cleavage rate matches that of the filament 
mechanism on the invading DNA, however, damaging cleavage of the host DNA is now much larger in the 
binary model, indicating loss of sequestration (blue arrow).  
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Figure 22. Reactions catalyzed and structures formed by Ire1 (or hIRE1) A. Splicing/RNase activity 
of Ire1/IRE1α (adapted with permission from Poothong et al. (2018)328). B. ATP dependent 
phosphorylation of protein side chains via kinase activity (IRE1 autophosphorylates by kinasing adjacent 
IRE1 chains when oligomerized). C. Human IRE1α forms foci in cells upon addition of the ER stress agent 
DTT (adapted with permission from Ghosh et al (2014)329). D. Schematic of IRE1. The kinase domain of 
IRE1 is colored light brown; the RNase domain is colored purple. TM, transmembrane domain (adapted 
with permission from Korennykh et al. (2009)18). E. The Splicing/RNase activity of IRE1 is activated upon 
oligomerization, induced via unfolded protein binding in the ER lumen (adapted with permission from 
Korennykh et al. (2009)18). F. Two orthogonal views of the filament formed by IRE1, determined via x-ray 
crystallography (adapted with permission from Korennykh et al. (2009)18). 
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Figure 23. Reaction catalyzed and structures formed by casein kinase 2 (CK2). A. Protein kinase activity 
of CK2. B. Negative stain EM of CK2 showing different oligomeric and filamentous forms (adapted with 
permission from Valero et al. (1995)266). Scale bar corresponds to 100 nm. C. Schematic of interconversion 
of oligomeric forms of CK2 and their dependence on ionic strength (adapted with permission from Seetoh 
et al. (2016)269). 
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Figure 24. Reaction catalyzed by and A. Reaction catalyzed by maize adenylate kinase (EC 2.7.4.3). B-D. 
Crystallographic packing in crystals of AK from maize (PDB code 1ZAK) resembling a single infinite 
filament, three protomers shown and colored distinctly (B), three filaments assembled around a 
crystallographic 3-fold (C) and viewed from the top (D). 
 
 
Figure 25. Reactions catalyzed by and structures formed by RIP1/RIP3 kinases. A. Protein 
phosphorylation reaction catalyzed by the kinase domain of RIP1 and RIP3. B. Formation of amyloid via 
the RHIM domain (brown) activates its kinase activity (adapted with permission from Li, et al. (2012)). C. 
Proposed structure of the RHIM or amyloid forming domains of RIP1 and RIP3 kinases (adapted with 
permission from Mompean, et al. (2018)282). D. Negative stain EM of filaments formed by RIP1 and the 
RHIM sequence of RIP3 (adapted with permission from Li, et al. (2012)). E. Foci formed in HeLa cells of 
YFP labeled RIP3 (adapted with permission from Li, et al. (2012)).  
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Figure 26. A. RIP2 forms foci in cells (adapted with permission from Gong et al. (2018)289). B. Negative 
stain EM image of RIP2-CARD filament (adapted with permission from Gong et al. (2018)289).  C. Filament 
of the ASC PYD with C3 symmetry. The filament can be thought of as composed of 3 single strands in a 
right-handed helix (adapted with permission from Lu et al. (2014)293). D. Models of inflammasome 
signaling involving protein filamentation (adapted with permission from Lu et al. (2014)293). 
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Figure 27. A. Foci formed by GFP labeled TORC1 (GFP-Kog1) under glucose starvation. Left, DIC image, 
right, confocal image (adapted with permission from Prouteau et al. (2017)296). B. Negative stain EM 
micrograph of TORC1 filament (adapted with permission from Prouteau et al. (2017)296). C. Single particle 
reconstruction at 27 Å resolution of TORC1 filament with constituent coordinate files fit into density 
(adapted with permission from Prouteau et al. (2017)296). D. Model of the biological role of TORC1 
filaments (adapted with permission from Prouteau et al. (2017)296).  
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Figure 28. A. Reaction catalyzed by glutamate synthase (Glt1 in yeast)(EC 1.4.1.13). B. Cytoophidia 
formed by GFP labeled Glt1p in S. cerevisiae (adapted with permission from Noree et al. (2010)24). C. 
Reaction catalyzed by asparagine synthetase (EC 6.3.5.4). D. Cytoophidia formed by GFP labeled 
asparagine synthetase (adapted with permission from Shen et al. (2016)26). E. Colocalization of various 
eIF2 and eIF2B proteins in cytoophidia, and lack of colocalization with other, unrelated proteins (adapted 
with permission from Noree et al. (2010)24). F. Reaction catalyzed by GDP-mannose pyrophosphorylase 
(EC 2.7.7.13). 
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Figure 29. A. Reaction catalyzed by xanthene oxidase (EC 1.1.3.22). B. Reactions catalyzed by enzymes 
of the purinosome (adapted with permission from An et al. (2008)111). C. Foci formed by members of the 
purinosome in purine depleted media. (i and iii) hTrifGART-GFP [(i) and green in (iii)] coclusters with 
hFGAMS-OFP [(ii) and red in (vi)] in HeLa cells under purine depleted conditions. (iv to vi) The control 
hC1THF-GFP [(iv) and green in (vi)], which does not participate directly in de novo purine biosynthesis, 
does not form clusters or colocalize with hFGAMS OFP [(v) and red in (vi)] in HeLa cells grown in purine-
depleted media. Scale bar, 10 mm (adapted with permission from An et al. (2008)111). 
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Figure 30. A. Reaction catalyzed by pyruvate kinase (EC 2.7.1.40). B. Large assembly formed by GFP 
labeled Cdc19 in yeast cells under hypoxic conditions (adapted with permission from Jin et al. (2017)33). 
C. Reaction catalyzed by enolase (EC 4.2.1.11). D. Reaction catalyzed by fructose bisphosphate aldolase 
(EC 4.1.2.13). E. G bodies (assemblies) of enolase and fructose bisphosphate aldolase in yeast under 
hypoxic conditions (adapted with permission from Jin et al. (2017)33). F. Assemblies of Mps1 kinase in 
Drosophila a single oocyte. Time=0 (green) and Time=30 minutes (red) show assemblies with exposure to 
CO2 (time=0, green), followed by exposure to ambient air whereupon the assemblies dissociate, then 
reintroduction of CO2 (time=30, red). The assemblies reappear in roughly the same locations and with 
nearly the same geometry. Foci also appear at the meiotic spindle (brighter spots near upper right)( adapted 
with permission from Gilliland et al. (2009)305). G. Reaction catalyzed by D-amino acid oxidase (EC 
1.4.3.3). 
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Figure 31. Biological roles of filament forming enzymes. Grey squares, inactive enzyme; copper 
spheres, active enzyme. 
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Table 1. Summary of Activities and Filament Structures for Selected Enzymes 
Enzyme Type of Structure Regulation of Enzyme Activity by Assembly Conditions Promoting Assembly References 
Metabolic Enzymes 
Acetyl-CoA carboxylase 
1 and 2  
(ACC1 and ACC2) 
(yeast, chicken, mice, 
human) 
Pathway: fatty acid 
biosynthesis 
Filaments 1-3 determined from single particle 
reconstructions using cryo-EM, 4-6 Å 
resolution. 
Filament 1: left-handed helix, 3 enzyme dimers 
per turn (120° between dimers), 154 Å 
between adjacent dimers71.  
Filament 2: left-handed helical backbone 
similar to Filament 1 with 3 dimers per turn 
but thinner, BC domain juts out71.  
Filament 3: Two left-handed filaments with 3 
dimers per turn (120° between dimers), and 
190 Å rise71.  
ACC2 also forms filament with citrate 
(negative stain TEM)20, 70. 
Filament 1: Citrate but no ACC 
phosphorylation, active enzyme71. 
Filament 2: Citrate, no ACC 
phosphorylation, palmitoyl-CoA, inactive 
enzyme71. 
Filament 3: BRCT domains of BRCA1 
bound to phosphorylated ACC1, inactive 
enzyme71. 
Filament of ACC1 with MIG12: 60x 
activation20. 
 
Filament 1: 10 mM citrate and  dephosphorylated 
ACC171. 
Filament 2: 10-fold molar excess of palmitoyl-
CoA to Filament 171. 
Filament 3: addition of BRCT domains of BRCA1 
to phosphorylated ACC1 (they bind 1:1 BRCT 
domain:ACC1 dimer)71. 
>5 mM Citrate induces filament formation by both 
ACC1 and ACC21, 20, 70. 
MIG12 promotes filamentation of ACC1 and 
ACC220. 
SPOT14 and MIG12 inhibit filament formation by 
ACC1 and ACC270. 
Forms foci when GFP labeled in yeast cells under 
nutrient starvation conditions24, 26. 
Kleinschmidt et al. (1969)1 
Meredith & Lane (1978)2 
Beaty et al. (1983)3 
Brownsey et al. (2006)66 
Kim et al. (2010)20 
Noree et al. (2010)24 
Park, et al. (2013)70 
Shen et al. (2016)26 
Jin et al. (2017)33 
Hunkeler et al. (2018)71 
 
 
 
ATP dependent 6-
phosphofructokinase  
(yeast genes Pfk1, Pfk2) 
(mammals, C. elegans) 
Pathway: glycolysis 
 
Single particle reconstruction from negative 
stain TEM, 25Å resolution. 
Filament of stacked tetramers which can 
assemble either of two ways resulting in 
either straight or kinked filament. 
Right handed helix with stacked PFKL 
tetramers related by a rotation of 221° and 
translation of 83 Å between subunits76. 
Average size is 6 tetramers. Kink leads to 
junction of ~130°. 
Effect on enzyme activity not yet known. 
Filaments form in response to substrate, 6-
phosphofuctose (in vitro) and citrate (in cells)76. 
Forms foci when GFP labeled in yeast cells under 
nutrient starvation or hypoxic conditions24, 26, 33. 
Formed foci at nerve cell synapses where energy 
demands are likely high75. 
Found in G-bodies33. 
Kemp (1971)4 
Telford et al. (1975)330 
Trujillo & Deal (1977)5 
Reinhart & Lardy (1980)6 
Foe & Trujillo (1980)77 
Schwock et al. (2004)331 
Ranjit et al. (2014)332 
Jang et al. (2016)75 
Shen et al. (2016)26  
Webb et al. (2017)76  
Jin et al. (2017)33  
Glucokinase  
(yeast gene Glk1) 
(fungi) 
Pathway: glycolysis 
Filament of S. cerevisiae Glk1 was resolved to 
3.8 Å by cryo-EM and single particle 
reconstruction90 and forms a right-handed, 
anti-parallel double helix.  
Enzyme is inhibited in the filament90. 
Bundles visible in cells form of Glk1-GFP fusions 
in response to glucose90. 
Filaments form in response to substrates (ATP and 
glucose, mannose, or glucosamine) or its 
products (ADP and sugar-6-phosphate)90. 
Modest filament formation in the presence of 
inhibitors N-acetylglucosamine-6-phosphate and 
N-acetylglucosamine90. 
Filaments do not form in vitro in the presence of 
fructose or galactose90. 
Stoddard et al. (2019)90 
CTP Synthase (CTPS) 
(bacterial, yeast genes 
Ura7 and Ura8, 
Drosophila, human) 
Pathway: pyrimidine 
biosynthesis (CTP) 
Filaments from bacteria and from human are 
composed of stacked tetrameric CTPS, but 
they assemble differently. 
The bacterial CTPS filament was resolved to 
4.6 Å by cryo-EM and single particle 
reconstruction and shows interdigitating 
tetramers with a rotation of ~49° between 
and ~3.7 per turn98. 
The human CTPS filament was resolved to 6.1 
Å by cryo-EM and single particle 
Bacterial CTPS is inhibited when in 
filament32, 96. 
Human CTPS is activated when in 
filament98. 
In bacteria, product (CTP) drives filamentation19. 
In human, filaments are favored in presence of 
substrates UTP and ATP, not products CTP and 
ADP98. 
Forms foci when GFP labeled in yeast cells under 
nutrient starvation conditions24, 26. 
Forms cytoophidia in Drosophila27. 
Werner et al. (2009)23 
Noree et al. (2010)24 
Liu et al. (2010)27 
Ingerson-Mahar et al. (2010)19 
Chen et al. (2011)41 
Carcamo et al. (2011)40 
Barry et al. (2014)96 
Aughey et al. (2014)97 
Noree et al. (2014)32 
Shen et al. (2016)26 
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reconstruction and shows stacked tetramers 
with less interdigitation than the bacterial 
form: ~30° per subunit and ~3 per turn98. 
Lynch et al. (2017)98 
Inosine monophosphate 
dehydrogenase (IMPDH) 
(yeast, Drosophila, 
human) 
Pathway: nucleotide 
synthesis (GTP) 
Filaments were characterized by single 
particle or helical reconstructions and 
negative stain TEM (20 Å resolution), and 
cryo-EM of Y12A IMPDH with GTP (8.7 Å 
resolution), and were found to be composed 
of stacked IMPDH octamers with a slight 
rotation between them (due to high 
symmetry, this could be considered either 
right or left-handed)128.  
Octamers resemble balls with holes in side, 
which can be open (assumed to be the active 
state) or collapsed (assumed to be the 
inactive)128.  
Filaments of open filaments have a rotation of 
30° between adjacent octamers, with each 
octamer spanning a distance of 111 Å. 
Filaments of collapsed octamers have a 
rotation of about 35.5° between adjacent 
octamers, and one octamer spans a distance 
of 94 Å128.  
Both open and collapsed octamers appear to 
be able to coexist in the same filament128.  
Also forms large structures known as 
“cytoophidia” in cells which may be 
bundles of filaments40, 122. 
Though it’s not known, the open form is 
considered the active form and the 
collapsed the inactive form128. 
IMPDH was shown to be stimulated 2.7-fold 
in filaments127 
ATP induces both types of filament128.  
GTP, a downstream product (or guanonsine) 
induces the collapsed type of filament128. 
IMP, a substrate, and NAD+, the cofactor consumed 
in the reaction, induce the open form128.   
Mycophenolic acid (an inhibitor) induces filaments 
in cells, GTP disperses filaments in cells, 
suggesting an inactive state333-334. 
MgATP stimulates filamentation in vitro and 
stimulates enzyme 2.7-fold127. 
Carcamo et al. (2011)40 
Liu et al. (2016)31 
Anthony et al. (2017)128 
Keppekke et al. (2018)124  
 
Glutamine (Q) 
synthetase 
(yeast gene Gln1) 
Forms pentameric rings that stack into a 
decamer (two rings with 30° twist between 
them) which further stack into filaments 
with ~10° twist between them101. 
Forms foci in cells as a result of nutrient 
starvation and heat stress24.  
Correlative light microscopy and negative 
stain TEM shows these to be composed of 
aligned filaments ~1 micron long101. 
Glutamine synthetase is inactive in the 
filament101. 
Filaments form at low pH101. 
Zinc induces decameric rings into filaments7. 
Filamentation in cells is reversible in the absence 
and presence of glucose25. 
Miller et al. (1974)7 
Frey et al. (1975)8 
Narayanaswamy et al. (2009)25 
Noree et al. (2010)24 
O’Connell et al. (2014)130 
Petrovska et al. (2014)101 
Shen et al. (2016)26 
β-glucosidase 
(plants including oat) 
Pathway: host defense 
Negative stain TEM shows trimeric rings that 
dimerize into hexamers and larger 
oligomers140-141. 
Single particle reconstructions suggest a 
difference in the twist between neighboring 
trimers forming a “tunnel” housing the 
active sites. In the multimers, the twist 
between trimers is 38°. In the hexamers this 
is 60°. The smaller twist seems to result in 
smaller side fenestrations presumably 
changing access to the active site140-141. 
Forms fibrils in cells termed stromacenters9. 
Two-fold lower KM and 1.6 lower kcat in the 
filament141. 
This effect may be related to steric hindrance 
of substrates and products entering and 
leaving the enzyme through openings in 
the filament vs. the hexamer (tighter 
binding but slower turnover)141. 
Activated upon fungal infection. Disassembled by 
CaCl2141. 
Gunning et al. (1965)9 
Nisius & Ruppel (1987)142 
Nisius et al. (1988)335 
Kim et al (2000)140 
Kim et al. (2005)141 
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CO2 reductase 
(bacteria, 
Acetobacterium woodii) 
Pathway: carbon fixation 
and energy conservation 
Filaments are 10-15 nm, with an apparent 
helical structure148 Filamentous form is 2-fold more active
148. Filaments are induced by 5-20 mM MgSO4, 20 mM MnCl2 or CaCl2148. 
Schuchmann et al. (2016)148 
Nitrilase 
(bacteria, fungi, plants) 
Pathway: detoxification 
Left-handed helical filament with 4-5 enzyme 
dimers per turn315. 
The filament is more active155. 
The helical twist of filaments of nitrilases 
from different organisms appears to 
correlate with substrate specificity, 
hypothesized to be due to substrate 
binding cleft size315. 
10 mM benzonitrile, but not aliphatic nitriles, 
induced filamentation and increased activity of 
the enzyme155.  
10% saturated ammonium sulfate and 50% (v/v) 
glycerol, increased temperatures, or enzyme 
concentrations induces the activated filament155. 
Wounding of plants (cutting or with herbicides) 
induces foci formation in plant cells21. 
Harper et al. (1977)10-11 
Cutler et al. (2005)21 
Thuku et al. (2007)152 
Thuku et al. (2009)156 
Chan et al. (2011)323 
Woodward et al. (2018)315 
CoA-Dependent 
acetaldehyde and alcohol 
dehydrogenase (AdhE) 
(bacteria, 
photosynthesizing 
unicellular organisms) 
Pathway: fermentation 
 Negative stain TEM showing “spiralosomes” 
of 20-60 subunits in rods of 45-120 nm in 
length with left-handed geometry22, 158. 
Model building with 7 copies per turn with 
right-handed helical geometry159.  
The helical filaments extend and become 
slimmer upon Fe2+ and NAD+ addition. 
Authors speculate that this is the active 
form, because it is more open, allowing 
substrates and products access to the 
enzymes, whereas the wider, shorter, 
more compact forms may be the inactive 
form of the enzyme22. 
Filaments found in cells, however ligands (Fe3+, 
NAD+) can induce structural changes in helical 
filaments22. 
Kessler et al. (1991)336 
Kessler et al. (1992)22 
Extance et al. (2013)159 
Laurenceau et al. (2015)158 
Glutamate (E) 
dehydrogenase 
(yeast gene Gdh2, 
mammals) 
Pathway: nitrogen and 
glutamate metabolism, 
energy homeostasis, 
amino acid synthesis, 
and in plants tolerance to 
herbicide, water deficit, 
pathogen infections  
Helical tubes in vitro visualized by negative 
stain TEM (9-9.3 subunits per turn)14. 
 
Though the effect on enzyme activity of 
filamentation is not known, conditions 
activating the enzyme also induce 
filamentation, and conditions deactivating 
the enzyme dissociate the filament, 
suggesting that filamentation increases 
enzyme activity180-181, 183. 
Stationary phase (i.e. nutrient starvation) induces 
cytoophidia in yeast26. 
GTP and NADH induce depolymerization (and are 
inhibitors) in vitro13, 15. 
ADP favors polymerization (and is an activator) in 
vitro13, 15. 
Olson & Anfinsen (1952)178 
Eisenbergy & Reisler (1971)12 
Huang et al. (1972)13 
Josephs & Borisy (1972)14 
Zeiri & Reisler (1978)15 
Shen et al. (2016)26 
Glutaminase 
(mammals) 
Pathway: nitrogen 
metabolism 
 
Negative stain TEM (35 Å resolution) with 
single molecule reconstruction and model 
fitting showing right-handed double helix 
with 53±2 nm rise per turn, strand 
inclination of 25°, and an average width for 
a single strand of 6.6±0.7 nm195. 
Filaments have increased catalytic 
activity195. 
Formed in vitro with purified protein, phosphate 
and phosphate-borate added to protein in Tris-
HCl induces polymers16. 
Olsen et al. (1970)16 
Ferreira et al (2013)195  
Petrovska et al. (2014)101 
β-lactamase-like protein 
(LACTB) 
(mammals) 
Pathway: unknown 
Appears as a braided filament in negative stain 
TEM199. 
Enzyme activity has not been investigated, 
and therefore it is not known how 
filamentation affects enzyme activity. 
Filaments are found in the intra-cristal part of the 
intermembrane space of mitochondria, spanning 
the cristae. 
Plianskyte et al. (2009)199 
2-Cys peroxiredoxins 
(archea, bacteria, 
eukaryotes) 
Pathway: H2O2 
metabolisom and 
detoxification, protein 
folding stress 
Filament has hollow core that binds unfolded 
proteins. Formed from stacks of decameric 
rings viewed by negative stain TEM325. 
Filaments are inactive in peroxidase 
activity, but active in chaperone activity 
(binding unfolded proteins, sequestering 
them to prevent aggregation). 
Redox stress, high hydrogen peroxide levels, heat 
shock, low pH, and site-specific phosphorylation 
induce filamentation. 
Wood et al. (2002)205 
Gourlay, et al. (2003)202, 325 
Phalen et al. (2006)324 
Saccoccia et al. (2012)207 
Angelucci et al. (2013)202 
Puerto-Galán et al. (2013)201 
Noichri et al (2015)200 
Teixeira et al. (2019)206  
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Ribonucleotide reductase 
(archea, bacteria, 
eukaryotes; yeast genes 
Rnr2 and Rnr4) 
Pathway: nucleotide 
metabolism 
cryo-EM, 2 types of filaments, 4.7-4.8 Å 
resolution, one a double helix (right-handed), 
the other having a filament of NrdE entwinned 
with a filament of NrdF (also right-handed)210. 
Enzyme is inhibited in both types of 
filaments210. 
High dATP (100 µM) induces filaments210.  
Filaments differ with respect to the presence or 
absence of NrdF protein210. 
Punctate foci seen in yeast with nutrient 
starvation25. 
Noree et al. (2010)25 
Ando et al. (2016)209 
Thomas et al. (2018)210 
Thomas et al. (2019)211  
Nucleic Acid Enzymes 
SgrAI 
(bacterial: Streptomyces 
griseus) 
Pathway: host defense 
Helical reconstruction and cryo-EM (3.5 Å 
resolution) shows left handed helix with ~4 
DNA bound enzyme dimers per turn 
(~90°)39.   
The enzyme is 200-1000x activated in the 
filament17, 38. 
 
Binding to double-stranded DNA containing the 
primary site sequence CRCCGGYG, and at least 
7 base pairs on either side, induce filamentation. 
Double-stranded DNA containing secondary site. 
sequences CCCCGGYG or XRCCGGYG will 
be bound by the enzyme, and will not induce 
filamentation but will join filaments formed by 
enzyme bound to primary site DNA. 
Park et al. (2010)17 
Shah et al. (2015)38 
Lyumkis et al. (2013)37 
Park et al. (2018)51-52 
Barahona et al. (2019)337 
Polley et al. (2019)39 
IRE1 
(eukaryotes) 
Pathway: unfolded 
protein response, 
response to stress 
X-ray crystal structure showed right-handed 
helical filament with 7 dimeric forms of the 
IRE1 chain per turn (~50°)18. 
Also forms foci in live cells18, 234-236. 
Filamentation activates splicing of TF 
mRNA 100,000-fold and possibly 
degradation of other mRNAs18. 
Upon dimerization via binding unfolded 
proteins, the kinase domains trans-
autophosphorylate lead to phosphorylated 
sites that likely stabilize the filamentous 
form18. 
Binding to ADP also favors filamentation18. 
Binding to unfolded proteins induces kinase 
activity that induces oligomerization, which then 
binds and splices particular mRNAs18, 230-234.  
In the filamentous form, the enzyme may cleave 
many mRNAs nonspecifically (i.e. RIDD 
activity), while in the dimeric form it cleaves 
only the particular mRNAs for transcription 
factors that induce the unfolded protein response 
pathway. 
Korennykh et al. (2009)18 
Li et al. (2010)236 
Ghosh et al. (2014)329 
RecA 
(E. coli) 
Pathway: Homologous 
recombination 
Right-handed helical filaments on DNA have 
been characterized by electron microscopy 
and x-ray crystallography (2.8-4.3 Å 
resolution) with ~60° per turn, 94 Å pitch, 
~6 RecA proteins per turn214. This filament 
has polarity (the two ends are not 
equivalent). 
Binding to ssDNA and ATP stimulates its 
filamentation and binding to dsDNA, 
which is stretched, causing duplex 
melting, allowing invasion by the single 
stranded DNA, good base pairing results 
in ATP hydrolysis and dissociation from 
the DNA 
Binding to ssDNA and ATP stimulates its 
filamentation which can then bind to dsDNA 
and perform its activity. 
Chen et al. (2008)214 
DnaA 
(E. coli) 
Pathway: DNA 
replication initiation 
Right handed helical filaments on DNA have 
been characterized by x-ray crystallography 
with 45° per turn, 178 Å pitch, 8 copies per 
turn218, 338. This filament has polarity (the 
two ends are not equivalent). 
Binding to ATP and specific sites in the 
origin of replication induces 
filamentation, which stretches and/or 
supercoils the DNA inducing strand 
melting (that allows the replicative helices 
to be loaded) 
Binding to ATP and specific sites stimulates 
filamentation which gives it its activity 
Erzberger et al. (2006)338 
Duderstadt et al. (2011)218 
Kinases and Innate Immunity Signaling Filaments 
Casein kinase CK2 
(human) 
Pathway: cell cycle 
control, cellular 
differentiation, and 
proliferation, circadian 
rhythm, apoptosis, and 
gene expression 
Protomer is heterotetramer (α2β2). Oligomers 
are deduced from native MS, IM-MS, and 
H/D exchange269. X-ray crystal structure 
shows linear form272.  
Filament is likely the inactive form of the 
enzyme266. 
High ionic strength (e.g. >0.5 M NaCl) disrupts 
filaments266. 
Ring form is favored in saturating concentration of 
substrates266. 
Valero, et al. (1995)266 
Seetoh et al. (2016)269 
Adenylate kinase 
(bacteria, plants) 
Pathway: nucleotide 
balance 
X-ray crystal structure shows linear filament 
with no helicity form from stacked 
hexamers274. 
 
Forms linear polymer in crystal packing.  
Not clear this occurs in vivo.  
Speculated to inhibit the activity based on 
steric/conformation arguments. 
Thought to occur at night, when enzyme activity is 
not needed, and to release water, though not 
understood how this is regulated274. 
Wild et al. (1997)274 
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RIP1/RIP3 kinase 
(mammals) 
Pathway: host defense, 
innate immunity 
Negative stain TEM. RIP homotypic 
interaction motif (RHIM) is a 5-6 residue 
segment that forms cross-beta amyloid 
structure upon self-association or 
association of RIP1 with RIP3281-282. 
Kinase activity activated by assembly276-278. 
Signaling induces association. 
The purpose of amyloid/fibril formation may be for 
feed-forward gain of function in which kinase 
activation and RIP1/RIP3 necrosome formation 
are mutually reinforcing281.  
Upon amyloid formation, transphosphorylation 
occurs which activates RIP1/RIP3281. 
Cho et al. (2009)276 
Li et al.  (2012)281 
Mompean et al. (2016)282 
Death domain containing 
 (vertebrates) 
Pathway: host defense, 
cell death, innate 
immunity 
 
Structures solved via helical reconstruction 
cryo-EM, single particle reconstruction 
cryo-EM and x-ray crystallography. 
Filaments assemble via death domain 
(CARD, PYD, DED). Some right-handed, 
others left-handed. Can appear as a triple 
helix. 
Filaments are the activated form of these 
signaling proteins. 
Proteins in this category have CARD or Death 
Domains that form filaments. Part of innate 
immunity in humans. Form in response to signal, 
often a ligand that induces dimerization of a 
death-domain containing protein, leading to 
seeding filament that is formed by another 
death-domain containing protein, which 
amplifies the signal and creates a scaffold for 
activation of downstream proteins, such as 
caspase-1 or kinases, leading to outcome such as 
increased transcription of inflammatory genes or 
induction of apoptosis or necrosis. 
Lin et al. (2010)290  
Wu et al. (2014)288 
Lu et al. (2014)293 
Diebolder et al. (2015)291 
Lu et al. (2016)292 
Gong et al. (2018)289 
TORC1  
(yeast) 
Pathway: 
nutrient/energy/redox 
sensor and controls 
protein synthesis 
Negative stain EM single particle 
reconstruction (27 Å resolution). Hollow 
tube or cylinder called TOROID, right 
handed with ~9 copies per turn296. 
Kinase activity is inactive in TOROID 
filament296. 
Glucose starvation296. 
Dependent on Rag GTPases for assembly296. Prouteau et al. (2017)
296 
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Table 2. Enzymes that form assemblies (in cells or in vitro), but structure and/or regulatory properties not yet determined. 
Enzyme/organism Type of Assembly Observed or Image 
Conditions triggering 
assembly in cells  
Is the 
assembly 
reversible? 
References 
Amino acid metabolism, protein synthesis, protein folding, protein degradation 
Glutamate (E) synthase 
(yeast gene Glt1) 
Pathway: ammonia assimilation cycle/glutamate biosynthetic process 
Cytoophidia, rods, and punctate foci 
Similar in stationary 
phase, diauxic phase, 
and log phase24, more 
in stationary phase26 
Shown to 
be motile, 
undergo 
sub-
diffusion26 
Noree et al. (2010)24 
Shen et al., (2016)26 
Asparagine synthetase 
(yeast gene Asn1, Asn2) 
Pathway: amino acid metabolism, nitrogen metabolism 
Cytoophidia and rods 
Increasing on going 
from log, to diauxic 
and stationary phases, 
glucose deprivation 
Yes25 
Narayanaswamy et al. (2009)25 
Shen et al. (2016)26 
Zhang et al. (2018)297 
Alanyl-tRNA synthetase 
(yeast gene Ala1) 
Pathway: protein synthesis, ala-tRNA aminoacylation 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Leucyl tRNA synthetase 
(yeast gene Cdc60) 
Pathway: protein synthesis, Leu-tRNA aminoacylation 
Punctate foci Stationary phase  Yes25 Narayanaswamy et al. (2009)25 
Cystathionine β-synthase 
(yeast gene Cys4) 
Pathway: amino acid metabolism, cysteine biosynthesis 
Punctate foci Stationary phase  Yes25 Narayanaswamy et al. (2009)25 
eIF2B, eIF2 
(yeast genes Gcd1 (eIF2b-γ, Gcd2 (eIF2B-δ), Gcd7 (eIF2B-β), Gcd6 (eIF2B-
ε), and Sui2 (eIF2-α), Gcn3 (eIF2B-α)) 
Cytoophidia, rods, and punctate foci 
 
Log and stationary 
phases, 
cycloheximide, 
acidification 
Yes25 
Noree et al. (2010)32  
Shen et al. (2016)26 
Nuske et al. (2018)300 
Peptidyl-prolyl cis-trans isomerase (cyclophilin) 
(yeast gene Cpr6) 
Pathway: Protein folding 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Glutamine tRNA synthetase  
(yeast gene Gln4) 
Pathway: protein synthesis, aminoacylating appropriate tRNA with glutamine 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Histidine tRNA synthetase 
(yeast gene Hts1) 
Pathway: protein synthesis, aminoacylating appropriate tRNA with histidine 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Isoleucine tRNA synthetase 
(yeast gene Ils1) 
Pathway: protein synthesis, aminoacylating appropriate tRNA with isoleucine 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Ribosome-associated molecular chaperones, ATPases  
(yeast genes Ssb1, Ssb2) 
Pathway: protein biosynthesis 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Threonyl tRNA synthetase 
(yeast gene Ths1) 
Pathway: protein synthesis, aminoacylating appropriate tRNA with threonine 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Valyl-tRNA synthetase 
(yeast gene Vas1) 
Pathway: protein synthesis, aminoacylating appropriate tRNA with threonine 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Threonine aldolase Punctate foci Stationary phase Not known Noree et al. (2010)24 
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(yeast gene Gly1) 
Pathway: glycine biosynthesis 
Multifunctional enzyme containing phosphoribosyl-ATP pyrophosphatase; 
phosphoribosyl-AMP cyclohydrolase, and histidinol dehydrogenase activities 
(yeast gene His4) 
Pathway: histidine biosynthesis 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
S-adenosylmethionine synthetase 
(yeast genes Sam1 and Sam2) 
Pathway: methionine metabolism, S-adenosylmethionine biosynthesis 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
Disaggregase (ATPase) 
(yeast gene Hsp104) 
Pathway: protein folding 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
ATPase involved in protein folding and NLS-directed nuclear transport 
(yeast gene Ssa1) 
Pathway: protein folding 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
HSP70 family ATP-binding protein 
(yeast gene Ssa2) 
Pathway: protein folding 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
Homoserine kinase 
(yeast gene Thr1) 
Pathway: threonine biosynthesis 
Punctate foci Stationary phase Not known Noree et al. (2010)
24 
Thayer et al. (2014) 
Non-ATPase regulatory subunit of the 26S proteasome 
 (yeast gene Rpn9) 
Pathway: protein degradation 
Punctate foci Stationary phase Not known Noree et al. (2010)
24, 
 
Cell wall biosynthesis 
GDP-mannose pyrophosphorylase 
(yeast gene Psa1) 
Pathway: cell wall biosynthesis, synthesizes GDP-mannose from GTP and 
mannose-1-phosphate in cell wall biosynthesis; required for normal cell wall 
structure 
Cytoophidia, rods and foci 
Stationary phase, 
sodium azide, 
staurosporine 
Not known Noree et al. (2010)
24 
Shen et al., (2016)26 
UDP-N-acetylmuramate-alanine ligase 
(the bacterium Caulobacter crescentus) 
Pathway: cell wall biosynthesis 
Cytoophidia, rods Normal cell growth Not known Werner et al. (2009)23 
5-phospho-ribosyl-1(alpha)-pyrophosphate synthetase 
(yeast gene Prs4) 
Pathway: synthesizes PRPP; which is required for nucleotide, histidine, and 
tryptophan biosynthesis 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
Purine metabolism 
Xanthene oxidase 
(mammals) 
Pathway: purine catabolism, nitrogen metabolism, important role in the 
catabolism of purines   
In vitro forms homotetrameric rings 
which can stack into fibers to form 
crystalline cores  
Formed in vitro Not known Angermuller et al. (1987)301 
Purinosome 
Phosphoribosyl- 
pyrophosphate amidotransferase 
(PRPPAT) 
(yeast gene Ade4, mammals) 
Pathway: Purine biosynthesis 
Colocalizes with other enzymes of the 
purinosome in punctate foci 
Stationary phase25, 
purine starvation111, 
female Drosophila 
germ line29 
Yes25, 111 
An et al. (2008)111 
Narayanaswamy et al. (2009)25 
Deng et al. (2012)112 
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Trifunctional GART enzyme 
(yeast gene Ade5,7, Drosophila gene Ade3, mammals) 
Pathway: Purine nucleotide biosynthesis 
Colocalizes with other enzymes of the 
purinosome in punctate foci, 
in Drosophila forms cytoophidia 
Stationary phase25, 
purine starvation111, 
female Drosophila 
germ line29 
Yes25, 111 
An et al. (2008)111 
Narayanaswamy et al. (2009)25 
Deng et al. (2012)112 
Lowe et al. (2014)29 
FGAMS/PFAS enzyme, phosphoribosylformylglycinamidine synthase 
(mammals) 
Pathway: purine biosynthesis, reaction step 4 of purinosome  
Colocalizes with other enzymes of the 
purinosome in punctate foci Purine starvation
111 Yes111 An et al. (2008)
111 
Deng et al. (2012)112 
Bifunctional PAICS enzyme 
(yeast gene Ade2, Drosophila gene Ade5, mammals) 
Pathway: Purine nucleotide biosynthesis 
Colocalizes with other enzymes of the 
purinosome in punctate foci, 
in Drosophila forms cytoophidia 
Stationary phase25, 
purine starvation111, 
female Drosophila 
germ line29 
Yes25, 111 
An et al. (2008)111 
Narayanaswamy et al. (2009)25 
Deng et al. (2012)112 
Lowe et al. (2014)29 
ADSL enzyme 
(mammals) 
Pathway: Purine biosynthesis 
Colocalizes with other enzymes of the 
purinosome in punctate foci Purine starvation
111 Yes111 An et al. (2008)
111 
Deng et al. (2012)112 
Bifunctional ATIC enzyme 
(yeast gene Ade17, mammals) 
Pathway: Purine biosynthesis,  
Colocalizes with other enzymes of the 
purinosome in punctate foci 
Stationary phase25, 
purine starvation111 Yes
25, 111 
An et al. (2008)111 
Narayanaswamy et al. (2009)25 
Deng et al. (2012)112 
Pyrimidine biosynthesis 
Trifunctional CAD enzyme  
(carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and 
dihydroorotase) 
(yeast gene Ura2) 
Pathway: Pyrimidine synthesis 
Punctate foci Stationary phase  Yes25 Narayanaswamy et al. (2009)25 
Adenylosuccinate synthetase 
(yeast gene Ade12) 
Pathway: Pyrimidine biosynthesis 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Carbohydrate metabolism 
Glycogen debranching enzyme 
(yeast gene Gdb1) 
Pathway: carbohydrate metabolism, contains glucanotranferase and alpha-1,6-
amyloglucosidase activities; required for glycogen degradation 
Cytoophidia Stationary phase  Not known Noree et al. (2010)
24 
Shen et al. (2016)26 
Pyruvate kinase 
(yeast gene Cdc19, mammals) 
Pathway: carbohydrate metabolism 
Punctate foci 
Stationary phase25, 302, 
glucose starvation302, 
heat shock302 
Yes25 
Narayanaswamy et al. (2009)25 
Saad et al. (2017)302 
Jin et al. (2017)33  
Enolase I 
(yeast gene Eno1) 
Pathway: carbohydrate metabolism 
G bodies Hypoxia  Not known Jin et al. (2017)33 
Enolase II 
(yeast-gene Eno2) 
Pathway: carbohydrate metabolism 
G bodies Hypoxia Yes303 Miura et al. (2013)
303 
Jin et al. (2017)33 
Fructose bisphosphate aldolase 
(yeast gene Fba1) 
Pathway: carbohydrate metabolism 
G bodies Hypoxia  Not known Jin et al. (2017)33 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)  
(yeast gene Tdh3) 
Pathway: carbohydrate metabolism 
G bodies Hypoxia  Not known Jin et al. (2017)33 
Phosphoglucose isomerase 
(yeast gene Pgi1) G bodies Hypoxia  Not known Jin et al. (2017)
33 
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Pathway: carbohydrate metabolism 
Tetrameric phosphoglycerate mutase  
(yeast gene Gpm1) 
Pathway: carbohydrate metabolism 
G bodies Hypoxia  Not known Jin et al. (2017)33 
Trehalose-6-P synthase/phosphatase complex (synthesis subunit) 
 (yeast gene Tps1) 
Pathway: carbohydrate metabolism, response to desication 
G bodies Hypoxia  Not known Jin et al. (2017)33 
Trehalose-6-P synthase/phosphatase complex 
(yeast gene Tps2) 
Pathway: response to stress, synthesis of the storage carbohydrate trehalose 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Alcohol dehydrogenase  
(yeast gene Adh2) 
Pathway: carbohydrate metabolism 
Punctate foci Stationary phase  Yes25 Narayanaswamy et al. (2009)25 
UDP-Glucose-pyrophosphorylase  
(yeast gene Ugp1) 
Pathway: carbohydrate metabolism 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Glycogen synthase 
(yeast gene Gsy1) 
Pathway: glycogen biosynthesis 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
Glycogen phosphorylase 
(yeast gene Gph1) 
Pathway: glycogen catabolism 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
Cell cycle 
Mps1/Polo kinases 
(Drosophila) 
Pathway: cell cycle regulation 
Punctate foci Hypoxia Yes305 Gilliland et al. (2009)
305 
Pandey et al. (2007)306 
Fatty acid and sterol metabolism 
Fatty acid synthase complex 
(yeast genes Fas1 and Fas2) 
Pathway: fatty acids and sterol metabolism 
Punctate foci Glucose starvation Yes28 Suresh et al. (2016)
28 
Jin et al. (2017)33 
Sterol 3-β-glucosyltransferase 
(yeast gene Atg26/Ugt51) 
Pathway: synthesis of sterol glucoside membrane lipids 
Punctate foci Stationary phase  Yes25 Narayanaswamy et al. (2009)25 
Other 
D-Amino acid oxidase 
(mammal) 
Pathway: detoxification (mammals), energy production (microorganisms) 
Light scattering indicated 
polymerization 
Purified protein in 
vitro Yes
308 Antonini et al. (1966)308 
Protein kinase of the PAK/Ste20 family 
(yeast gene Kic1) 
Pathway: cell wall organization 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Gamma-aminobutyrate (GABA) transaminase 
(yeast gene Uga1) 
Pathway: Nitrogen utilization 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Serine hydroxymethyltransferase  
(yeast gene Shm2) 
Pathway: one-carbon metabolism 
Punctate foci Stationary phase Yes25 Narayanaswamy et al. (2009)25 
Thioredoxin peroxidase 
(yeast gene Tsa1) Cytoophidia  Stationary phase Not known Shen et al. (2016)
26 
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Pathway: cell redox homeostasis 
Glutamine amidotransferase (GATase II) 
(yeast gene Dug2) 
Pathway: glutathione catabolic process 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
Aminolevulinate dehydratase 
(yeast gene Hem2) 
Pathway: heme biosynthesis 
Punctate foci Stationary phase Not known Noree et al. (2010)24 
Protein of unknown function with glutathione-S-transferase domain 
(Drosophila gene Fax) 
Pathway: unknown 
Punctate foci Female Drosophila germ line Not known Lowe et al. (2014)
29 
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